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In prokaryotes, the Clustered Regularly Interspersed Short Palindromic 
Repeats (CRISPR)-mediated defense system provides an RNA-based, adaptive 
immunity against bacteriophages and plasmids. The defense process is 
comprised of three key stages, including spacer acquisition, CRISPR RNA 
(crRNA) maturation and CRISPR interference. During the interference 
process, a surveillance complex, composed of CRISPR-associated (Cas) 
protein(s), is guided by a sequence-specific crRNA to target invading genetic 
elements for cleavage. The unique properties make CRISPR/Cas system a 
very valuable tool in several distinct areas, such as genomic manipulation, 
transcriptional regulation as well as the generation of phage-resistant strains 
for the industrial fermentation.  
The CRISPR/Cas systems are categorized into the three major types (I, II 
and III). Although Csx3 protein is exclusively found in the Type III systems, 
Csx3 is not included into any of the Cas families and its function is largely 
unknown. In this study, we report the crystal structures of Archaeoglobus 
fulgidus Csx3 (AfCsx3) in free form, in complex with manganese ions and in 
complex with an RNA fragment at 2.95 Å, 3.0 Å and 2.9 Å, respectively. 
AfCsx3 harbors a ferredoxin-like fold and forms dimer both in the crystal and 
in solution. Our structure-based biochemical analysis demonstrates that the 
RNA binding sites and cleavage sites are located at two separate surfaces of 
the AfCsx3 dimer, suggesting a model to bind, tether and cleave the incoming 
RNA substrate. In addition, AfCsx3 displays robust 3’-deadenylase activity in 
the presence of manganese ions, which strongly suggests that AfCsx3 
 vi 
 
functions as a deadenylation exonuclease. Taken together, our results indicate 
that AfCsx3 is a Cas protein involved in RNA deadenylation and provide a 
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CHAPTER 1 Introduction 
Prokaryotes have developed various resistance mechanisms during the 
co-evolution of host and virus. In addition to the known innate defense 
strategies, such as the blockage of phage adsorption (Heller 1992), 
restriction-modification (R-M) system (Roberts, Belfort et al. 2003) and 
abortive infection system (Fineran, Blower et al. 2009), bacteria and archaea 
have also evolved an adaptive CRISPR/Cas immune system (Makarova, 
Grishin et al. 2006). In brief, the RNA-based CRISPR/Cas system provides 
resistance to previously encountered bacteriophages and plasmids. 
Interestingly, this newly discovered immune system is also heritable and has 
the ability to be passed on from one generation to the next. 
In this chapter, we make a brief introduction of the discovery and 
classification of CRISPR/Cas system, followed by the detailed description of 
the defense mechanisms.  
1.1 Discovery of the CRISPR/Cas system  
1.1.1 Identification of CRISPR Repeats  
DNA repeats were first discovered in the Escherichia coli K12 genome. 
The research group accidentally found several regularly spaced repeats during 
the sequencing of an iap gene encoding an isoenzyme alkaline phosphatase 
(Ishino, Hideo Shinagawa et al. 1987). Adjacent to the iap gene, there was a 
sequence array containing five highly homologous 29 nt sequences spaced by 
various 32 nt sequences. Later on, the same group sequenced the entire array 
and in total 14 repeat units were found (Nakata, Amemura et al. 1989). 
Meanwhile, similar repeat arrays were discovered in many other bacterial 
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strains. Using this same technique, repeat arrays were subsequently found in 
many other archaeal species by different research groups, such as the currently 
well-studied A. fulgidus (Klenk, Clayton et al. 1997) and Sulfolobus 
solfataricus (Sensen 1998). With the rapid development of genome 
sequencing technologies, an increasing number of repeat arrays were 
described with an abundance of disparate acronyms such as short repeats (SR), 
long tandemly repeated repetitive (LTRR), large clusters of tandem repeats 
(LCTR) and spacers interspersed direct repeats (SPIDR). To resolve the 
confusion, Jansen and Mojica proposed a more explicit acronym CRISPR, 
short for Clustered Regularly Interspaced Short Palindromic Repeats (Jansen, 
Embden et al. 2002).  
1.1.2 Identification of CRISPR Spacers  
Within the CRISPR loci, variable sequences of similar size are separated 
by repeat sequences. These variable sequences, known as spacers, are 
juxtaposed between two neighboring repeats and have been shown to be 
highly homologous to viral DNAs (Mojica, Diez-Villasenor et al. 2005, 
Pourcel, Salvignol et al. 2005) or plasmids and chromosomal sequences 
(Mojica, Diez-Villasenor et al. 2005). These two groups simultaneously 
reported their findings in 2005 by analyzing more than 30 bacterial and 16 
archaeal species in total. Subsequently, a third group further confirmed these 
findings by the observation that spacers of 14 analyzed bacterial species 
shared sequence similarity to phage genomes (Bolotin, Quinquis et al. 2005). 
These results suggested that spacers might be originated from the invading 
viral DNAs or genetic elements. Thus, the CRISPR loci can be described as 
the genetic retention of historical infections. 
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In addition, a literature survey by Mojica showed that the hosts carrying 
CRISPR spacers were resistant to viruses and/or plasmids harboring the 
matching sequences (Mojica, Diez-Villasenor et al. 2005). Another study 
showed that Streptococcus thermophilus strains with larger CRISPR loci are 
sensitive to only a relatively small number of infective phages (Bolotin, 
Quinquis et al. 2005). Taken together, these findings led to the hypothesis that 
CRISPR arrays may be involved in the acquired defense system against 
invading nucleic acid elements (Bolotin, Quinquis et al. 2005, Mojica, 
Diez-Villasenor et al. 2005, Pourcel, Salvignol et al. 2005). 
1.1.3 Identification of Cas Proteins  
In the host genome, gene cassettes encoding a series of proteins are 
frequently seen in the vicinity of CRISPR loci. The proximity of the genomic 
location of the CRISPR arrays and gene cassettes suggests that they may be 
functionally correlated. Initial bioinformatics analyses identified four gene 
families within these cas gene cassettes, including cas1, cas2, cas3 and cas4 
(Jansen, Embden et al. 2002). Currently, over 45 cas gene families have been 
identified (Haft, Selengut et al. 2005). Biochemical and genetic analysis 
demonstrate that both the CRISPR transcripts and Cas proteins participate in 
the acquired and heritable immunity system against invading genetic elements 
(Haft, Selengut et al. 2005, Makarova, Aravind et al. 2011). 
1.2 Classification of CRISPR/Cas Systems    
The CRISPR/Cas systems provide adaptive immunity to protect host cell 
(most archaea and many bacteria) against bacteriophage and foreign genetic 
elements. This RNA-based immune process is mediated by a series of Cas 
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proteins with great diversity. The classification of CRISPR/Cas systems are 
based on the differences in phylogeny, locus organization and protein 
components (Bhaya, Davison et al. 2011, Makarova, Haft et al. 2011). 
 
Figure 1-1 Primary classification of CRISPR/Cas systems based on the 
phylogenetic analysis of Cas1 Proteins (Adopted from Haft, Selengut et al. 
2005). 
The phylogenetic tree is constructed using 54 representative Cas1 proteins. 
Csm/Cmr cannot be distinguished from other subtypes, since Csm and Cmr 
highly co-occur with other subtypes and share the same set of Cas1 proteins. 
As a consequence, in total 7 subtypes are shown based on the phylogenetic 
analysis of Cas1 Proteins. 
Among the identified protein components, Cas1 and Cas2 are found in 
the great majority of these systems, which suggests a common and important 
role of these two proteins in the CRISPR/Cas systems (Makarova, Haft et al. 
2011). Cas1 is a metal-dependent endonuclease against various DNA 
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substrates, including single-stranded DNAs (ssDNA), double-stranded DNAs 
(dsDNA) (Wiedenheft, Zhou et al. 2009) and branched DNAs (Babu, 
Beloglazova et al. 2011). Cas2 is a metal-dependent nuclease against 
single-stranded RNAs (ssRNA) (Beloglazova, Brown et al. 2008), dsDNAs 
(Nam, Ding et al. 2012, Ka, Kim et al. 2014) or both (Gunderson, Mallama et 
al. 2015). Both Cas1 and Cas2 appear to be involved in the incorporation of 
foreign genetic elements into host genome. In particular, as Cas1 is universally 
present in all systems, the phylogenetic analysis of Cas1 protein played a 
fundamental role in establishing the primary classification of the CRISPR/Cas 
systems (Figure 1-1) (Haft, Selengut et al. 2005).  
There are nine sets of subtype-specific cas genes in total. Eight of the 
modules are named after representative organisms in which a single 
CRISPR/Cas locus exists. These cas subtypes include: csa (Aeropyrum pernix), 
cst (Thermotoga neapolitana), csh (Haloarcula marismortui), csm 
(Mycobacterium tuberculosis), csd (Desulfovibrio vulgaris), csy (Yersina 
pestis), cse (Escherichia coli), and csn (Neisseria meningitidis). The ninth 
module, Cas module RAMP (cmr), so far has been found to coexist with at 
least one of the other modules (Haft, Selengut et al. 2005).  
Among the diverse constituent proteins of the CRISPR/Cas systems, 
several unique signature proteins were found exclusively in a particular system. 
This prompted the reclassification of the CRISPR/Cas systems into the three 
major types (I, II and III) and 11 subtypes according to the presence of these 





Figure 1-2 Advanced classification of CRISPR/Cas systems (Adopted and 
modified from Makarova, Haft et al. 2011).  
The representative operon architectures are shown for eleven subtypes of 
CRISPR/Cas systems. The signature genes for the three major systems are 
shaded in green, while the subtype-specific signature genes are shaded in red. 
Across all the subtypes, Cas proteins are categorized as several groups: large 
subunits (L), small Cascade subunits (S), RAMP subunits (R), RAMP 
endonuclease (RE) and transcriptional regulators (T). 
The signature protein for the Type I system is Cas3 which is typically 
comprised of a helicase domain and an HD nuclease domain. The order in the 
arrangement of these two domains varies in different subtypes. In other cases, 
helicase and nuclease domains of Cas3 are separated into two individual 
proteins known as Cas3’ and Cas3’’, respectively. Interestingly, it was also 
reported that the full-length Cas3 (helicase and nuclease domains) appears to 
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be fused with other Cas proteins. On such example is the Cas2-Cas3 fusions in 
Type I-F subtypes (Richter, Gristwood et al. 2012) and occasionally 
Cas3-Cse1 fusions in several Type I-E subtypes (Westra, van Erp et al. 2012). 
In addition to Cas3 signature protein, another signature feature of the Type I 
system is the CRISPR-associated complex for antiviral defense (Cascade) 
composed of distinct subtype-specific proteins (Brouns, Jore et al. 2008, 
Haurwitz, Jinek et al. 2010). Regardless of the distinct protein components, 
the Cascade complexes of different subtypes show similar structural profiles 
(Wiedenheft, van Duijn et al. 2011, Nam, Haitjema et al. 2012, Huang, Jin et 
al. 2013, Jackson, Golden et al. 2014, Mulepati, Héroux et al. 2014, Plagens, 
Tripp et al. 2014, Zhao, Sheng et al. 2014). The Type I system requires 
Cascade and Cas3 to recognize and target foreign DNA for cleavage 
(Sinkunas, Gasiunas et al. 2011). The six different subtypes (Type I-A to I-F) 
in the Type I system are the most diverse among the three systems (Makarova, 
Haft et al. 2011). Several subtype-specific signature proteins are proposed to 
distinguish among the Type I subtypes. The Cas8 homologues, Cas8a, Cas8b 
and Cas8c represent Type I-A, I-B and I-C, while Cse1 and Csy1 represent 
Type I-E and I-F, respectively. In addition to Cas3, Type I-D also features a 
Type III signature protein Cas10, yet it is still included into Type I due to the 
similar protein composition to other Type I subtypes. The co-occurrence of 
two type-specific signature proteins indicates a possible horizontal gene 
transfer between I-C and III-B subtypes (Makarova, Haft et al. 2011). 
Cas9 is the signature protein for the Type II system. It is a 
multi-functional large protein with a recognition domain, two nuclease 
domains (HNH and RuvC) and a C-terminal domain. In spite of the significant 
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sequence diversity, Cas9 proteins from different species possess similar 
structural arrangement and globular architecture (Chylinski, Le Rhun et al. 
2013, Chylinski, Makarova et al. 2014, Jinek, Jiang et al. 2014, Nishimasu, 
Ran et al. 2014). So far, Cas9 has been shown to be required for the 
integration of new spacers, crRNA biogenesis as well as CRISPR interference 
targeting invading DNA (Garneau, Dupuis et al. 2010, Deltcheva, Chylinski et 
al. 2011, Sapranauskas, Gasiunas et al. 2011, Heler, Samai et al. 2015, Wei, 
Terns et al. 2015). In addition, trans-acting small RNAs (tracrRNAs) are 
encoded on the opposite strand of the CRISPR array. Similar to Cas9, 
tracrRNAs are also involved in all the three stages of Cas9-mediated immune 
defense in the Type II system (Garneau, Dupuis et al. 2010, Deltcheva, 
Chylinski et al. 2011, Heler, Samai et al. 2015, Wei, Terns et al. 2015). As is 
shown in Figure 1-2, two subtypes of Type II systems are distinguished by the 
presence of csn2-like gene (subtype II-A) or cas4-like gene (subtype II-B). 
Subtype II-C was subsequently proposed, as it contains the minimal cas 
operon including cas1, cas2 and cas9 genes (Chylinski, Makarova et al. 2014).  
The signature protein for the Type III system is Cas10, which typically 
consists of a HD domain, a distinct domain, a Zn-finger domain and a 
polymerases-like palm domain (Makarova, Aravind et al. 2011, Cocozaki, 
Ramia et al. 2012, Zhu and Ye 2012). Cas10, also known as Csm1 or Cmr2, is 
the key component of the effector complex of the Type III system and may 
function as the large subunit based on their position in the complex (Rouillon, 
Zhou et al. 2013, Spilman, Cocozaki et al. 2013, Staals, Agari et al. 2013, 
Osawa, Inanaga et al. 2015, Taylor, Zhu et al. 2015). So far, two subtypes of 
Type III systems are distinguished by the presence of either Csm2 (subtype 
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III-A) or Cmr5 (subtype III-B). Within the Type III systems, both Csm and 
Cmr complexes are proposed to be involved in the ultimate processing of 
mature crRNA following the Cas6-mediated primary cleavage of pre-crRNA 
(Hatoum-Aslan, Maniv et al. 2011, Hale, Majumdar et al. 2012). In addition, 
the Type III-A and III-B subtypes have been demonstrated to target both 
dsDNA (Marraffini and Sontheimer 2008, Deng, Garrett et al. 2013, Goldberg, 
Jiang et al. 2014, Peng, Feng et al. 2015), as well as complementary ssRNA 
(Hale, Zhao et al. 2009, Staals, Agari et al. 2013, Staals, Zhu et al. 2014, 
Tamulaitis, Kazlauskiene et al. 2014, Zebec, Manica et al. 2014).  
1.3 Distribution of the CRISPR/Cas Systems in Bacteria and Archaea  
CRISPR arrays have been discovered in more than 40 % of the bacterial 
and 85 % of the archaeal genomes (Rousseau, Gonnet et al. 2009). Generally, 
the Type I and Type III CRISPR/Cas systems are widespread in diverse 
bacterial and archaeal species, whereas the Type II systems have only been 
found in a few bacterial lineages (Makarova, Aravind et al. 2011).  
Additionally, the distribution of different Type I subtypes appears to be 
quite different between bacteria and archaea. The Type I-A, I-B and I-D 
subtypes are more prevalent in archaeal species. The Type I-A systems are 
mostly present in thermophilic archaeal species. The Type I-B systems are 
present in various bacterial and preferably archaeal lineages (Makarova, Haft 
et al. 2011), while the Type I-D systems are predominantly distributed in 
cyanobacteria and euryarchaeal species (Makarova, Wolf et al. 2013). On the 
contrary, the Type I-C, I-E and I-F subtypes are more prevalent in bacterial 
species. The Type I-C system are commonly present in diverse bacterial 
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species, mainly in the firmicutes phylum (Haft, Selengut et al. 2005). The 
Type I-E system can be found in the majority of bacterial species but rarely in 
individual euryarchaeal organisms (Brouns, Jore et al. 2008, Makarova, Wolf 
et al. 2013). The Type I-F system is strictly present in bacterial organisms, 
mostly in Gammaproteobacteria (Makarova, Wolf et al. 2013). 
The Type III systems are widespread in prokaryotes with the preference 
to thermophiles and are more commonly present in archaea. The types III-A 
and III-B subtypes have a high incidence in co-occurrence in both bacterial 
and archaeal domains. In addition, the Type III subtypes also co-occur with 
several Type I subtypes, such as I-A, I-B, and I-D. In particular, the Type 
III-B is so far found to strictly coexist with other subtypes.  
1.4 Mechanisms of CRISPR/Cas Systems 
In spite of the diversification of CRISPR/Cas systems, all the systems 
commonly include three main stages: spacer acquisition, crRNA maturation 
and CRISPR interference (Brouns, Jore et al. 2008, Deveau, Garneau et al. 
2010, Karginov and Hannon 2010).   
1.4.1 Spacer Acquisition 
1.4.1.1 Essential Cas Proteins Responsible for Spacer Acquisition  
Cas1 and Cas2 are ubiquitous in almost all the CRISPR/Cas systems and 
they are initially predicted to be involved in spacer acquisition, indicated by 
the fact that they are not required for crRNA processing or antiviral defense in 
Type I (Brouns, Jore et al. 2008) and Type III systems (Hale, Zhao et al. 2009). 
Later, two groups independently demonstrated that both Cas1 and Cas2 
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proteins are sufficient for spacer acquisition in E. coli Type I-E system 
(Datsenko, Pougach et al. 2012, Yosef, Goren et al. 2012).  
To date, structures of several Cas1 proteins have been determined along 
with their respective biochemical characterizations (Wiedenheft, Zhou et al. 
2009, Babu, Beloglazova et al. 2011, Kim, Shin et al. 2013, Nunez, Kranzusch 
et al. 2014). The Cas1 protein from Pseudomonas aeruginosa is capable of 
cleaving ssDNA and dsDNA in vitro, especially catalyzing dsDNA and 
generating products with length of approximately 80 bp. However, it is still 
unknown how the ~80 bp fragment is further processed into 32 bp (the length 
of spacer) fragments and integrated into the CRISPR array. The metal binding 
site of the Cas1 is comprised of several conserved acidic and a histidine 
residue which are essential for nuclease activity. Alanine substitutions of these 
conserved residues abolished Cas1 nuclease activity against DNA substrates 
(Wiedenheft, Zhou et al. 2009). In addition to the cleaving of ssDNA and 
dsDNA, the Cas1 protein from E. coli has been demonstrated to cleave various 
branched DNAs, such as Holliday junctions, replication forks, 3’-flaps, 
5’-flaps, Y-junctions and splayed arm duplex (Babu, Beloglazova et al. 2011). 
It is worth noting that the Cas1 protein from A. fulgidus was subsequently 
demonstrated to show nuclease activity against ssRNAs (Kim, Shin et al. 
2013). Nonetheless, due to the high variation in amino acid sequences, Cas1 
proteins may show diverse nuclease activities against different types of nucleic 
acids. It is worth noting that the nuclease-inactivated Cas1 fails to acquire new 
spacers both in vivo and in vitro (Nunez, Kranzusch et al. 2014, Nunez, Lee et 
al. 2015).  
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The encoding genes of Cas1 and Cas2 are typically located closely in the 
genome. Several Cas2 proteins have been studied structurally and 
biochemically (Beloglazova, Brown et al. 2008, Nam, Ding et al. 2012, Ka, 
Kim et al. 2014, Nunez, Kranzusch et al. 2014, Gunderson, Mallama et al. 
2015). All these Cas2 proteins possess a common RNA recognition motif. The 
ribonuclease activity of Cas2 protein (Sso1404) has been experimentally 
demonstrated in vitro. Cas2 cleaves the RNA substrate by targeting the 
phosphodiester linkage in the U-rich region (Beloglazova, Brown et al. 2008). 
In addition, Cas2 from Streptococcus pyogenes and Bacillus halodurans 
showed nuclease activity towards dsDNA (Nam, Ding et al. 2012, Ka, Kim et 
al. 2014), while the Cas2 protein from Legionella pneumophila has both 
RNase and DNase activities (Gunderson, Mallama et al. 2015). Although Cas2 
proteins are highly different in biochemical properties, it has been 
demonstrated that the nuclease activity of Cas2 is not required in the spacer 
adaption stage (Nunez, Kranzusch et al. 2014, Nunez, Lee et al. 2015). In 
contrast, the intact structure of Cas2 is required for Cas1-mediated spacer 
integration. 
1.4.1.2 Additional Cas Proteins Involved in Spacer Acquisition 
In addition to the key protein components Cas1 and Cas2, it is suggested 
that several accessory factors also play a role in spacer acquisition.  
Csn2 is exclusively found in the Type II-A systems and is predicted to be 
involved in CRISPR adaptation (Makarova, Haft et al. 2011). The structures of 
Csn2 reveal a ring-shaped tetramer with a central cavity composed of 
conserved positively-charged residues (Nam, Kurinov et al. 2011, Ellinger, 
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Arslan et al. 2012, Koo, Jung et al. 2012, Arslan, Wurm et al. 2013). Multiple 
biochemical assays demonstrated that Csn2 showed dsDNA binding activity 
through its central cavity in a Ca2+-dependent manner. It is proposed that the 
Csn2 tetrameric complex binds DNA ends and moves along the DNA 
substrate by a screw-like motion. However, Csn2 showed no catalytic activity 
towards DNA substrates, suggesting that Csn2 might function as an accessory 
protein during spacer acquisition. Two recent studies have shown that the 
absence of Csn2 inhibits the incorporation of spacer, indicating that Csn2 is 
required for space acquisition in Type II-A system. Furthermore, in addition to 
Cas1, Cas2 and Csn2, Cas9 and tracrRNA are also required for the integration 
of new spacers (Heler, Samai et al. 2015, Wei, Terns et al. 2015). 
Cas4 proteins have been found in several subtypes, such as subtype I-A, 
I-B, I-C, I-D and subtype II-B. Cas4 protein shows sequence similarity to 
RecB family nuclease (Makarova, Grishin et al. 2006). Later, Cas4 protein 
was demonstrated to be a 5' to 3' ssDNA exonuclease in S. solfataricus (Zhang, 
Kasciukovic et al. 2012). In addition to exonuclease activity, a following study 
showed that SsCas4 also has ATP-independent helicase activity toward 
dsDNA (Lemak, Beloglazova et al. 2013). The presence of 5’ to 3’ 
exonuclease and helicase activities suggest that Cas4 might produce 3’-DNA 
overhangs that could be potential intermediates for new spacer acquisition. 
There are two more evidences that support the involvement of Cas4 in spacer 
acquisition. The first, Cas1-Cas4 fusion proteins have been found in several 
subtypes. The second, Cas4 from Thermoproteus tenax has been 
experimentally demonstrated to interact with Cas1-Cas2 fusion protein to form 
a complex in vitro (Plagens, Tjaden et al. 2012). Taken together, these 
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observations strongly suggest that Cas4 and Cas1 are functionally involved in 
spacer acquisition. 
1.4.1.3 Essential Genetic Elements Responsible for Spacer Acquisition  
Apart from the proteins involved in spacer adaptation, both the repeat 
unit and leader sequence are also essential for acquisition (Yosef, Goren et al. 
2012). At least one repeat unit is sufficient for the system to integrate a new 
repeat-spacer unit (Yosef, Goren et al. 2012). Moreover, the efficiency of 
adaptation is similar no matter how many repeat units are originally in the 
array, indicating that the sequence specificity, rather than the repetitive pattern 
of the repeat, is the essential factor for spacer adaptation. 
The leader sequences, present at 5’ distal end of the CRISPR arrays, are 
non-coding sequences ranging from about 100–500 bp. In E. coli, systematic 
deletion of the 5’ leader sequence showed that the reduction of leader 
sequence from 100 bp to 40 or 20 bp completely abolished the acquisition 
capability (Yosef, Goren et al. 2012). Associated with the observation that 
novel spacers always insert immediately downstream of the leader region 
(Deveau, Barrangou et al. 2008, Horvath, Romero et al. 2008), the minimal 
functional element within the leader sequence may serve as a genomic 
positioning signal (GPS) for the new spacer integration. The normally 
polarized insertion may also serve as a record of past invasions based on the 
order of spacers (Barrangou, Fremaux et al. 2007). It is worth noting that the 
deletion of the TATA box within the leader sequence had little impact on the 
acquisition efficiency. Since TATA box is required for transcription of the 
CRISPR array (Pougach, Semenova et al. 2010, Pul, Wurm et al. 2010), it is 
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suggested that the CRISPR transcription and spacer adaptation may be two 
irrelevant processes.  
1.4.1.4 Mechanistic Insights into Spacer Adaptation  
In addition to the evidence that Cas1 and Cas2 are required for spacer 
acquisition in E. coli subtype I-E system in vivo (Datsenko, Pougach et al. 
2012, Swarts, Mosterd et al. 2012, Yosef, Goren et al. 2012), it has also been 
shown that the Cas1-Cas2 complex is sufficient to integrate protospacer DNA 
oligonucleotides into acceptor plasmid in vitro (Nunez, Lee et al. 2015). These 
results provide deeper insights into the mechanism of protospacer integration. 
Conceptually, the process of spacer acquisition may include three steps: spacer 
selection, generation of spacer material, and integration of new spacer-repeat 
unit into the CRISPR array.  
The selection of spacer is initiated by the recognition of protospacer 
adjacent motif (PAM). PAM is a conserved type-specific short nucleotide 
sequence which is ubiquitously found next to the protospacer, at least for the 
Type I and Type II CRISPR/Cas systems. In addition to various sequences and 
sizes (2~5 nt) among different subtypes, PAM may also locate on either side 
of the protospacer (Lillestøl, Shah et al. 2009, Mojica, Diez-Villasenor et al. 
2009). In most cases, the arrangement for the Type I and Type II systems is 
5'-PAM-protospacer and 5'-protospacer-PAM, respectively. Originally, the 
PAM is found to be crucial for targeting invader DNAs in the interference 
stage (Deveau, Barrangou et al. 2008, Fischer, Maier et al. 2012, 
Lopez-Sanchez, Sauvage et al. 2012, Parey, Fritz et al. 2013, Konermann, 
Brigham et al. 2015). It is reasonable to speculate that the PAM is also used 
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for the spacer selection since newly acquired spacers are mostly derived from 
PAM-neighboring protospacers (Datsenko, Pougach et al. 2012, Swarts, 
Mosterd et al. 2012). This is further supported by the fact that the PAM is 
required for the incorporation of spacers for subsequent CRISPR interference 
(Datsenko, Pougach et al. 2012, Swarts, Mosterd et al. 2012). Although the 
recognition mechanism is well studied in the stage of CRISPR interference 
(see 1.4.3.1.2.1), it is suggested that the PAM recognition in spacer acquisition 
and CRISPR interference are not necessarily identical since these two 
processes are accomplished by different protein machineries. The PAM 
sequence is likely to be recognized and serve as a cleavage site of protospacer. 
This is supported by the observation in E. coli that the first nucleotide of 
newly acquired spacers is identical to the last nucleotide of PAM sequence 
(Datsenko, Pougach et al. 2012, Goren, Yosef et al. 2012, Swarts, Mosterd et 
al. 2012, Yosef, Goren et al. 2012, Savitskaya, Semenova et al. 2013, 
Shmakov, Savitskaya et al. 2014). Since PAM sequences are not integrated 
into the CRIPSR locus during spacer acquisition, this specific motif acts as the 
differentiated marker between the protospacer of invading DNA (nonself) and 
the spacer of CRISPR locus (self). Therefore, in addition to facilitate the 
process of DNA targeting, the PAM requirement may also prevent 
autoimmunity by distinguishing self- and nonself-genetic elements during the 
immune defense (Deveau, Barrangou et al. 2008, Lemak, Beloglazova et al. 
2013, Shah, Erdmann et al. 2013). 
Once located, the generation of spacer material might be initiated by the 
fragmentation of invading DNA (Swarts, Mosterd et al. 2012). Since 
CRISPR/Cas system and R-M system are reported to collaborate functionally 
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in S. thermophiles (Dupuis, Villion et al. 2013), it is suggested that the R-M 
system might be responsible for the fragmentation of invading DNA and the 
generation of potential spacer material for acquisition. It should also be noted 
that the size of the new spacer is mostly identical to pre-existing spacers, in 
the presence or absence of spacers in the CRISPR array (Yosef, Goren et al. 
2012). Therefore, the length of a new spacer is not determined by pre-existing 
repeat-spacer units in the CRISPR array. Furthermore, in vitro acquisition 
assay showed no length preference of spacer for integration (Nunez, Lee et al. 
2015), indicating that in addition to Cas1-Cas2 complex, a ruler protein 
machinery is needed for the generation of new spacers.  
Following the generation of new spacers, integration of spacers occurs 
immediately downstream of the leader. The Cas1-Cas2 complex has been 
shown to nick the integration site of CRISPR array both in vivo and in vivo 
(Arslan, Hermanns et al. 2014, Nunez, Lee et al. 2015). Therefore, a two-step 
model is proposed for integration mechanism that 3’-OH of anti-protospacer 
strand first attacks and ligates to 5’-phosphates of anti-repeat strand followed 
by the process that 3’-OH of protospacer strand attacks and ligates to 
5’-phosphates of repeat strand (Figure 1-3) (Nunez, Lee et al. 2015).  
In the model, the full integration leaves each stand with a repeat gap 
which is likely further repaired by a DNA repair system, leading to the 
duplication of repeat unit (Figure 1-3) (Nunez, Lee et al. 2015). Interestingly, 
a previous study has shown that Cas1 might be involved in the DNA repair 
processes, since Cas1 interacts with several key components of the DNA 
repair systems (Babu, Beloglazova et al. 2011). Similar to retroviral 
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integration and DNA transposition, polymerases and ligases are required to fill 
in sequence gaps and to seal the phosphodiester backbone, respectively 
(Craigie and Bushman 2012). Apparently, more evidences are required to 
elucidate the mechanism of spacer adaptation mediated by CRISPR/Cas and 
the collaborated systems. 
 
Figure 1-3 Mechanism of spacer integration (Adopted and modified from 
Nunez, Lee et al. 2015). 
The model reveals stepwise nucleophilic attacks during spacer integration. The 
3’-OH of anti-protospacer strand first attacks and ligates to 5’-phosphates of 
anti-repeat strand, leading to the formation of half-site intermediate. Following 
the first nucleophilic attack, the 3’-OH of spacer strand attacks and ligates to 
5’-phosphates of repeat strand. The repeat duplication is accomplished by the 
repair of two gaps at repeat region. 
Most recently, the study of spacer acquisition in Type II-A system 
revealed a different mechanism. In contrast to the Type I-E system, spacer 
acquisition in Type II-A system is mediated by Cas1, Cas2, Csn2, Cas9 as 
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well as tracrRNA and none of the five elements is dispensable (Heler, Samai 
et al. 2015, Wei, Terns et al. 2015). Cas9 identifies the PAM sequence of 
to-be-acquired protospacers through the PAM-binding motif, similar to the 
PAM recognition for DNA targeting (Anders, Niewoehner et al. 2014, Jinek, 
Jiang et al. 2014). PAM recognition by Cas9 appears to be dispensable for 
spacer acquisition, as the abolishment of PAM recognition by Cas9 has no 
effect on the efficiency of adaptation. Instead, newly acquired spacers are 
randomly derived from protospacers without PAM sequences (Heler, Samai et 
al. 2015, Wei, Terns et al. 2015). In addition, neither nuclease activity of Cas9 
nor pre-existing spacers are needed for spacer acquisition which suggests that 
other proteins that are involved in the type II spacer acquisition have not yet 
been identified. In future, more details are to be determined to fully understand 
the spacer acquisition in Type II system. 
1.4.2 CrRNA Maturation  
The second stage is crRNA maturation, in which CRISPR arrays are 
transcribed and processed into mature crRNAs containing a unique 
repeat-spacer sequence (Figure 1-4) (Bhaya, Davison et al. 2011, Makarova, 
Haft et al. 2011). Mature crRNAs are key elements of the CRISPR/Cas 
interference machinery and guide the interference machinery to target 
invading genetic elements for cleavage. Due to the CRISPR/Cas 
diversification, the systems have evolved different molecular mechanisms for 
the mature crRNAs biogenesis. The maturation of crRNAs is mainly 
composed of two steps, CRISPR transcription and crRNA processing.  
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In the first step, the CRISPR array is transcribed into a precursor crRNA 
(pre-crRNA) (Figure 1-4). This step is the common theme among all the 
systems. The leader sequence functions as main promoter for the transcription 
of the CRISPR array, while the absence of leader region leads to significant 
decrease of transcription (Lillestøl, Shah et al. 2009, Wurtzel, Sapra et al. 
2010, Deng, Kenchappa et al. 2012). The transcription of pre-crRNA is mostly 
unidirectional and transcripts derived from reverse strands of the CRISPR loci 
have also been reported (Lillestøl, Shah et al. 2009, Stern, Keren et al. 2010, 
Deng, Kenchappa et al. 2012, Zhang, Rouillon et al. 2012). 
 
Figure 1-4 crRNA maturation processing pathways in CRISPR-/Cas 
systems (Adopted and modified from Bhaya, Davison et al. 2011).  
The mechanisms of crRNA processing vary among CRISPR/Cas systems. In 
Type I systems, the endoribonucleases of subtypes I-A, I-B and I-D process 
the pre-crRNA and produce intermediates for further trimming of the 3’ ends. 
Pre-crRNAs in subtypes I-C, I-E and I-F undergo a one-step possessing by 
Cas5d, Cas6e and Cas6f, respectively. In Type II systems, both the tracrRNA 
and pre-crRNA are co-processed by RNase III in the presence of Cas9. 
Afterward, a second exo-/endo-ribonuclease processing generates the mature 
crRNAs. In Type III systems, the standalone Cas6 cleaves pre-crRNA and 
generate intermediates for further trimming of the 3’ ends. 
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In the second step, the pre-crRNA is processed by subtype-specific 
endoribonucleases within the repeat region, to yield short crRNA fragments 
containing a single spacer sequence with both terminals flanked by partial 
repeat sequences (Figure 1-4). In the Type II, Type III and several Type I 
subtypes, the mature crRNAs are generated by a stepwise processing with a 
further trimming of the cleaved crRNA (Figure 1-4).  
1.4.2.1 CrRNA Biogenesis in Type I and Type III CRISPR/Cas Systems 
In both Type I and Type III CRISPR/Cas systems, a metal-independent 
Cas6-homologue or Cas6-like endoribonuclease cleaves pre-crRNA within the 
repeat region to yield the mature or intermediate crRNAs (Carte, Wang et al. 
2008, Haurwitz, Jinek et al. 2010, Sashital, Jinek et al. 2011, Nam, Haitjema et 
al. 2012).  
In Type I-E and I-F subtypes, crRNA maturation only requires a one-step 
cleavage by the endoribonuclease which is also a subunit of the interference 
complex (Haurwitz, Sternberg et al. 2012, Sternberg, Haurwitz et al. 2012, 
Niewoehner, Jinek et al. 2014). The mature crRNA is generated by the 
repeat-specific Cas6e or Cas6f endoribonuclease (Haurwitz, Jinek et al. 2010, 
Gesner, Schellenberg et al. 2011, Przybilski, Richter et al. 2011, Sashital, 
Jinek et al. 2011). The mature crRNA typically contains a 8 nt 5’ handle with 
5’-hydroxyl, a single spacer sequence and a 3’ stem-loop structure with either 
a 3’ phosphate in Type I-F (Wiedenheft, van Duijn et al. 2011) or a 2’-3’ 
cyclic phosphate termini in Type I-E (Jore, Lundgren et al. 2011). It was 
observed that both Cas6e and Cas6f remain bound to the 3’ stem-loop 
structure of the mature crRNA, serving as a platform for complex assembly 
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(Haurwitz, Sternberg et al. 2012, Sternberg, Haurwitz et al. 2012, Niewoehner, 
Jinek et al. 2014).  
The Type I-C is an exception among Type I subtypes due to the absence 
of Cas6-encoding gene (Makarova, Haft et al. 2011). Instead of Cas6 protein, 
Cas5d, a homolog to the Cas5 protein, has been shown to possess pre-crRNA 
cleavage activity and is responsible for crRNA maturation (Garside, 
Schellenberg et al. 2012, Nam, Haitjema et al. 2012). Cas5d-mediated 
cleavage produces a mature crRNA containing an 11 nt 5’ handle with 
5’-hydroxyl, a single spacer sequence and a 3’ stem-loop structure with a 2’-3’ 
cyclic phosphate termini. Cas5d showed a rather weak affinity with the 3’ 
cleaved RNA (Garside, Schellenberg et al. 2012, Nam, Haitjema et al. 2012), 
which differs from the examples of Cas6e and Cas6f (Gesner, Schellenberg et 
al. 2011, Jore, Lundgren et al. 2011, Wang, Preamplume et al. 2011, 
Wiedenheft, Lander et al. 2011). Time-course gel mobility-shift assay 
provides the evidence for the release of cleaved product after Cas5d-mediated 
cleavage. It is showed that after rapid binding between Cas5d and pre-crRNA, 
the retarded band decreased over time, producing a smaller band which has 
been proven to be cleaved RNA products (Garside, Schellenberg et al. 2012, 
Nam, Haitjema et al. 2012). 
One common feature of Type I-C, I-E and I-F subtypes is that cleaved 
crRNAs are not processed any further. Another common feature is that the 
crRNAs of these three subtypes have stable stem-loop structures. There are 
two possible functions of the stable stem-loop structures. During the cleavage 
process, the cleavage sites of crRNA is strictly conserved at the linkage of 
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unpaired and paired region at 3’ terminus, indicating this structural property 
might help exhibit the cleavage site to the catalytic sites of endoribonuclease 
and facilitate the cleavage of crRNA. In Type I-C, despite the release of 
cleaved product after Cas5d-mediated cleavage, one Cas5d subunit is 
proposed to attach to the mature crRNA by interacting with 3’ handle 
stem-loop structure of the crRNA in the interference complex. Following the 
observation that the endoribonuclease for crRNA maturation is also a subunit 
of the interference complex, it has been suggested that the stem-loop structure 
might also help maintain the stable interaction between mature crRNA and 
other protein components in the interference complex (Jore, Lundgren et al. 
2011, Wiedenheft, van Duijn et al. 2011, Nam, Haitjema et al. 2012, Huang, 
Jin et al. 2013).  
In contrast to the one-step crRNA maturation in Type I-C, I-E and I-F 
subtypes, Cas6-homologue endoribonucleases generate intermediate crRNAs 
that are further processed into mature crRNAs by unknown mechanisms in 
Type I-A, I-B, I-D and Type III systems (Deltcheva, Chylinski et al. 2011, 
Lintner, Kerou et al. 2011, Hale, Majumdar et al. 2012, Richter, Gristwood et 
al. 2012, Zhang, Rouillon et al. 2012, Staals, Agari et al. 2013, Plagens, Tripp 
et al. 2014). Cas6-homologue endoribonucleases specifically recognize and 
cleave 8 nt of the repeat at 3’ terminus, in the absence or presence of 
stem-loop structures within the repeat sequence. This site-specific cleavage 
leads to the generation of 8 nt 5’ handle which is not processed any further. 
However, the 3’ handles are often shortened, possibly due to the de-protection 
caused by the disassociation of endoribonucleases and intermediate crRNAs.  
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In S. solfataricus, Type I-A Cas6 was shown to release crRNA according 
to the multiple turnover catalysis (Sokolowski, Graham et al. 2014). 
Consequently, the 3’ handle of crRNA may be exposed for unexpected 
chemical and/or enzymatic catalysis, which is consistent with the observation 
that 3’ handles are rarely detected in the cellular crRNA pool of T. tenax 
possessing a Type I-A system (Plagens, Tripp et al. 2014). Similar to Type I-A, 
the 3’ end of crRNAs is also shortened in Type I-B and I-D subtypes, 
indicating the disassociation of the crRNA and Cas6 after pre-crRNA cleavage 
(Kunin, Sorek et al. 2007, Yang, Wang et al. 2011, Richter, Lange et al. 2013, 
Konermann, Brigham et al. 2015). The processing of 3’ repeat handles has 
been shown to generate various lengths ranging from 0 to 5 nt and no regular 
pattern has been found so far in the Type I-A, I-B, I-D subtypes (Richter, 
Zoephel et al. 2012, Elmore, Yokooji et al. 2013, Hein, Scholz et al. 2013, 
Plagens, Tripp et al. 2014). 
In both Type III-A and III-B systems, two major mature crRNA species 
have been found to coexist in a single strain, such as S. epidermidis and T. 
thermophiles (Marraffini and Sontheimer 2010, Hale, Majumdar et al. 2012, 
Juranek, Eban et al. 2012, Zhang, Rouillon et al. 2012, Staals, Agari et al. 
2013). In despite of the distinct length among different species, two mature 
crRNA species can be differentiated by a specific 6 nt length in a single specie. 
For example, the lengths of two mature crRNA species are 43 and 37 nt in 
Type III-A system of S. epidermidis (Marraffini and Sontheimer 2010), 40 and 
46 nt in Type III-B system of T. thermophiles (Juranek, Eban et al. 2012), as 
well as 39 and 45 nt in Type III-B system of Pyrococcus furiosus (Staals, 
Agari et al. 2013).  
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In Type III-A system, it is suggested that a ruler mechanism may be 
responsible for the further processing of the intermediate crRNAs 
(Hatoum-Aslan, Maniv et al. 2011). It has been shown that Csm3 is required 
for the second step of crRNA maturation, which is supported by the fact that 
csm3-deficient mutant failed to generate mature crRNAs while intermediate 
crRNAs were normally generated (Hatoum-Aslan, Maniv et al. 2011). Since 
Csm3 comprises the backbone along the crRNA in Csm interference complex, 
Csm3 might be used as a ruler for further processing of intermediate crRNAs 
(Staals, Zhu et al. 2014, Tamulaitis, Kazlauskiene et al. 2014). 
Correspondingly, a single Csm3 subunit approximately expands a 6 nt length 
along the crRNA in Csm complex. Therefore, heterogeneous Csm complexes 
with a difference of one Csm3 subunit may explain the specific 6 nt length 
difference between two mature crRNA species. Similar to Csm3 in Type III-A 
systems, Cmr4 are key components for backbone assembly in Type III-B 
systems and a single Cmr4 subunit also expands a 6 nt length along the crRNA 
in Cmr complex (Benda, Ebert et al. 2014).  
In summary, intermediate crRNAs are assembled into Csm/Cmr complex 
with the 5’ end anchored as a reference point while the unprotected 3’ end is 
accessible for further chemical and/or enzymatic catalysis (Hatoum-Aslan, 
Samai et al. 2013, Rouillon, Zhou et al. 2013, Benda, Ebert et al. 2014, Staals, 
Zhu et al. 2014, Osawa, Inanaga et al. 2015). The length of unprotected 3’ end 
is dependent on the number of Csm3/Cmr4 subunits, leading to the specific 6 
nt length difference between two major mature crRNA species.  
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1.4.2.2 CrRNA Biogenesis in Type II CRISPR/Cas Systems 
Type II CRISPR/Cas systems contain a minimal locus with only three or 
four genes (cas1, cas2, cas9 and csn2/cas4/nil) (Chylinski, Makarova et al. 
2014). In addition, tracrRNAs are encoded on the opposite strand of the 
CRISPR/Cas locus. RNA sequencing analysis has shown two major crRNA 
species, a 66 nt intermediate form and a mixture of 39~42 nt mature forms, 
indicating a stepwise maturation of crRNA in Type II systems (Deltcheva, 
Chylinski et al. 2011).  
With the lack of Cas6-encoding genes found in Types I and III systems,  
RNase III processes pre-crRNAs in the presence of Cas9 and a tracrRNA. The 
tracrRNAs complement with repeat regions of the pre-crRNA, forming RNA 
duplexes that are stabilized by Cas9. The Cas9-RNA duplexes complexes then 
recruit the housekeeping RNase III to cleave duplexes to yield intermediate 
crRNAs and mature 75~78 nt tracrRNAs (Deltcheva, Chylinski et al. 2011, 
Chylinski, Le Rhun et al. 2013, Karvelis, Gasiunas et al. 2013). The cleavage 
occurs within the repeat region of the pre-crRNA to generate the intermediate 
crRNA containing a single spacer sequences with both termini flanked by 
partial repeat sequences. Co-processing of pre-crRNA and tracrRNA indicates 
that the cleavage also occurs within the anti-repeat region of the precursor 
tracrRNA. The abolishment of RNase III-mediated cleavage by making a 
mutation in the repeat/anti-repeat regions indicates that duplex formation of 
tracrRNA and pre-crRNA is essential for co-processing (Deltcheva, Chylinski 
et al. 2011). Pre-crRNA deficient and tracrRNA deficient mutants failed to 
produce mature tracrRNA and intermediate crRNA, respectively. Similarly, 
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RNase III-deficient and Cas9-deficient mutants failed to process both 
tracrRNA and pre-crRNA (Deltcheva, Chylinski et al. 2011). 
Following the generation of intermediate crRNAs, an additional trimming 
or cleavage occurs at 5’ end or within the spacer regions. The intermediate 
crRNAs are further processed into mature crRNAs in the composision of 
5’-spacer-repeat-3’ with partial sequences of spacer and repeat (Deltcheva, 
Chylinski et al. 2011). It is worth noting that the composition of mature 
crRNAs shows significant differences between Type II and Type I & III 
systems, corresponding to the distinct interference machineries. The secondary 
processing is mediated by an unknown endonucleolytic or exonucleolytic 
catalysis. Considering the fixed length ranges of the mature crRNAs in vivo, it 
is predicted that a secondary endonucleolytic cleavage might occur within the 
spacer regions restricted by sequence specificity in combination of a specific 
range of distances from the RNase III-mediated cleavage site. An alternative 
strategy is to cooperate with a trimming mechanism, possibly mediated by 
exosome complex, to remove the unprotected 5’ region and generate the 
mature crRNAs.  
1.4.3 CRISPR Interference 
Upon subsequent challenge, mature crRNAs guide Cas9 or surveillance 
complexes to target the invading nucleic acid. In despite of the single protein 
Cas9, the surveillance complexes of Type I and III systems are assembled by 
diverse subtype-specific proteins and mature crRNAs. The ribonucleoprotein 
complexes recognize and distinguish nonself-genetic elements and accomplish 
the cleavage and/or degradation of foreign nucleic acids. 
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1.4.3.1 Cascade-Mediated Defense Process in Type I 
1.4.3.1.1 Composition of Type I Surveillance Complexes 
As mentioned above, the endoribonucleases remain associated with 
mature crRNA in Type I-E and I-F subtypes, serving as a platform for 
complex assembly (Haurwitz, Sternberg et al. 2012, Sternberg, Haurwitz et al. 
2012, Niewoehner, Jinek et al. 2014). So far, the complex assembly in these 
two subtypes has been well studied. Additionally, the complex assembly in 
Type I-A and I-C has also been described (Lintner, Kerou et al. 2011, Richter, 
Gristwood et al. 2012, Plagens, Tripp et al. 2014), while little is known about 
the complex assembly in Type I-B and I-D subtypes. 
In Type I-A system from S. solfataricus, although Cas6 releases crRNA 
product after cleavage, it is still co-purified with tagged Cas7, along with Cas5, 
Csa5 and crRNA, suggesting that Cas6 is still an essential part of the complex 
probably by interacting with core protein components of the complex (Lintner, 
Kerou et al. 2011). However, an alternative Cascade formation was found in T. 
tenax when tagged Csa5 co-purified with Cas7, Cas5, Cas3’, Cas3’’ and Cas8a 
while no Cas6a was found (Plagens, Tripp et al. 2014). These six proteins, 
along with a synthetic mature crRNA, yielded a Cascade complex sufficient 
for cleavage of dsDNA. It is worth noting that both Cas3’ helicase and Cas3’’ 
nuclease are assembled into the protein complex even before crRNA loading, 
suggesting that Cas3’ and Cas3’’ are fundamental components of Cascade 
complex instead of being recruited during immune response.  
The structure of a Type I-A Cas7 family protein from S. solfataricus was 
determined, providing insight into the interactions between proteins and 
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between protein-nucleic acid. It was proposed that multiple Cas7 proteins 
form the helical backbone of I-A Cascade along the crRNA with the 5’ end of 
crRNA capped by Cas5 in S. solfataricus (Lintner, Kerou et al. 2011). In 
contrast, although T. tenax Cas7-crRNA forms a helical multimer structure, no 
helical structures were observed in Cas7-embedded I-A Cascade (Plagens, 
Tripp et al. 2014). Cas8a, another core subunit, may function as large subunit 
based on the size, yet its function is largely unknown. A previous study 
showed that Csa5 of T. tenax preferentially bound ssDNA, suggesting Csa5 
may function as the small Cascade subunit involved in target DNA recognition 
(Niewoehner, Jinek et al. 2014). There are still many open questions in the 
Type I-A system and, in future, Cascade structure (cryo-EM or crystallization) 
would be helpful to elucidate the composition and stoichiometry for the Type 
I-A surveillance complex.  
In the Type I-C subtype, Cas5d acts as the pre-crRNA endoribonuclease 
for crRNA maturation (Garside, Schellenberg et al. 2012, Nam, Haitjema et al. 
2012). Strikingly, the dual functional property distinguishes Cas5d protein into 
catalytic subunit and non-catalytic subunit in Type I-C Cascade (Nam, 
Haitjema et al. 2012). The I-C Cascade is proposed to contain one mature 
crRNA, one copy of Cas8c, two copies of Cas5d and six copies of Cas7, with 
a total mass of ~400 kDa. Within the complex, the catalytic Cas5d subunit 
attaches to the mature crRNA by interacting with 3’ handle of the crRNA. In 
addition, the 5’ handle of the crRNA is presumably bound by a non-catalytic 
Cas5d subunit. Likewise, the Cas7 family protein forms the backbone of I-C 
Cascade. Furthermore, Cas8c protein may act as both large and small subunits 
and bind to non-catalytic Cas5d subunit. Type I-C Cascade complex is able to 
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restore the interference of plasmid DNA in Cas-Deficient E. coli, while the 
absence of any of the components failed to silence the plasmid (Nam, 
Haitjema et al. 2012). 
In Type I-E, The essential proteins for CRISPR-based resistance were 
determined by complementing Cas-Deficient E. coli with various 
combinations of cas genes from E. coli K12 (Jore, Lundgren et al. 2011). The 
I-E Cascade is a ~405 kDa complex built up by five Cas proteins and a single 
61 nt mature crRNA. Within the complex, the subunit stoichiometry is 
1:2:1:1:6 for the five protein components, Cse1, Cse2, Cas5, Cas6e and Cas7 
(Figure 1-5). So far, many approaches have been used to determine the 
structure of E. coli Cascade, including transmission electron microscopy in 
combination with small angle X-ray scattering (Jore, Lundgren et al. 2011), 
cryo-electron microscopy (cryo-EM) (Deltcheva, Chylinski et al. 2011), and 
recently X-ray crystallography (Jackson, Golden et al. 2014, Mulepati, Héroux 
et al. 2014, Zhao, Sheng et al. 2014). In agreement with the former EM 
structures, the atomic structures also revealed a seahorse-shaped profile with 
the same subunit stoichiometry, providing important insights into the 
mechanism of Cascade assembly and target recognition.  
According to the structure, six helical-arranged Cas7 subunits bind to the 
main body of crRNA while Cas6e subunit binds to the 3’ end of the mature 
crRNA (Figure 1-5). Additionally, two Cse2 subunits attach to the front of the 
helical backbone formed by Cas7 (Deltcheva, Chylinski et al. 2011). It is 
further observed that the 5’ handle of the crRNA locates just between subunits 
Cas5 and Cse1 (Jackson, Golden et al. 2014). This configuration, allows for 
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sufficient exposure of the crRNA to target the dsDNA and at the same time to 
protect the crRNA from RNase degradation.  
It is proposed that Cascade may be assembled in a specific order. 
Following the crRNA maturation, the Cas6e subunit remains tightly attached 
to the mature crRNA by interacting with 3’ handle of the crRNA. 
Cas6e-crRNA then recruits Cas5 which binds to the 5’ handle of the crRNA, 
leading to the formation of hook-like structure of crRNA (Jackson, Golden et 
al. 2014, Mulepati, Héroux et al. 2014, Zhao, Sheng et al. 2014). Due to the 
similar palm-thumb structure, Cas5 and six copies of Cas7 subunits bind to the 
crRNA in a conserved tandem palm-thumb arrangement (Figure 1-5). The 
septa-palm-thumb arrangement enables the Cascade backbone to be 
intertwined. Additionally, two copies of Cse2, known as small Cascade 
subunit, bind the spacer region of crRNA backbone. Each Cse2 is interacting 
with three Cas7 subunits. Finally, the large subunit Cse1 is assembled into the 
Cascade by interacting with Cas5, Cas7 and Cse2 (Figure 1-5). Both Cse1 and 
Cse2 are involved in target DNA interaction, while Cse1 is also responsible 
for the target recognition (Jore, Lundgren et al. 2011, Wiedenheft, Lander et al. 
2011, Wiedenheft, Sternberg et al. 2012). This step completes the Cascade 
assembly and ensures the presence of a surveillance complex that constantly 
screens the cell for potential target DNAs. 
In addition, two subtype I-F CRISPR/Cas systems have been studied in 
Pseudomonas aeruginosa and Pectobacterium atrosepticum (Wiedenheft, van 
Duijn et al. 2011, Huang, Jin et al. 2013). The I-F Cascade is proposed to 
contain one mature crRNA, a single copy of Csy1, Cas5, Cas6f and six copies 
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of Cas7 family protein, with a total mass of ~350 kDa. The subunit 
stoichiometry of I-F Cascade is similar to other Type I Cascade complexes. In 
P. aeruginosa, it was observed that six copies of Cas7 form the 
crescent-shaped backbone of crRNA. In addition, Csy1 and Cas5 form a stable 
heterodimer in vitro (Wiedenheft, van Duijn et al. 2011, Huang, Jin et al. 
2013). The follow-up study in P. atrosepticum provides additional evidence 
that Cas7 elongates by oligomerization and directly interacts with Csy1 and 
Cas6f (Wiedenheft, van Duijn et al. 2011, Huang, Jin et al. 2013). As 
mentioned, Cas6f remains tightly attached to the mature crRNA by interacting 
with 3’ handle of the crRNA (Haurwitz, Sternberg et al. 2012, Sternberg, 
Haurwitz et al. 2012). Based on these results, the arrangement of protein 
components is proposed as Cas51-Csy11-Cas76-Cas6f1, along the 5’ to 3’ of 
crRNA in I-F Cascade complex. In agreement of the observations in other 
Type I subtypes, the 5’ handle of the crRNA is capped by Cas5. Furthermore, 
Csy1 interacts with both Cas5 and Cas7, suggesting that Csy1 might be the 
fusion of large and small subunits and responsible for target DNA binding and 
recognition (Richter, Gristwood et al. 2012).  
1.4.3.1.2 Target Recognition and R-loop Formation  
1.4.3.1.2.1 Protospacer Adjacent Motif  
It was originally found that phages were able to overcome Type II 
immunity system of S. thermophiles by generating mutations on the PAM 
sequence next to the protospacer (Deveau, Barrangou et al. 2008). Follow-up 
studies provide more evidence that the mutation of the conserved PAM 
significantly abolish interference against phages and plasmids in the Type I 
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and Type II CRISPR/Cas systems (Fischer, Maier et al. 2012, Lopez-Sanchez, 
Sauvage et al. 2012, Parey, Fritz et al. 2013, Konermann, Brigham et al. 2015). 
These findings suggest that invading DNA molecules can remain undetected 
by mutating the PAM sequence and therefore escape the 
CRISPR/Cas-mediated immune resistance of host cells. In the Type I Cascade, 
the large subunit Cse1 is responsible for the recognition of PAM sequences. It 
is proposed that Cascade binds the dsDNA and scans along the target until 
Cse1 identifies the PAM sequence in the targeted strand of invading dsDNA 
and initiates the interference process (Sashital, Wiedenheft et al. 2012, 
Mulepati, Héroux et al. 2014, Tay, Liu et al. 2015).  
1.4.3.1.2.2 Seed Sequence  
In addition to mutations in the PAM region of the protospacer, invaders 
can also escape CRISPR/Cas immunity by introducing mutations at certain 
positions within the protospacer (Semenova, Jore et al. 2011, Wiedenheft, van 
Duijn et al. 2011). The complementary matching between the crRNA and the 
target are highly indispensable in the region containing 8 nucleotides in the 
vicinity of PAM sequence. This critical region resembles the seed sequence of 
small RNAs in eukaryotic RNA interference (RNAi). Similar to the property 
of PAM, mutations in the seed sequence can also allow the invaders to evade 
immune resistance by interfering the interaction between Cascade and 
protospacer DNA. It is worth noting that multiple mismatches within the 
spacer sequence other than the seed region are tolerated for the recognition of 
invader DNA. As a result, a single crRNA may be used repeatedly to target 
numerous related phages, which limits the possibilities for immune resistance 
of phages.  
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1.4.3.1.2.3 R-loop Formation  
Recent structural studies of the Cascade in complex with target DNA 
provide important insights into the recognition mechanism for DNA 
protospacer (Jackson, Golden et al. 2014, Mulepati, Héroux et al. 2014, Zhao, 
Sheng et al. 2014). The Cascade binds target dsDNA molecules by base 
pairing crRNA to the complementary DNA strand in seed region to form a 
stable RNA-DNA hybrid which initiates the R-loop formation of the unpaired 
DNA strand (Jore, Lundgren et al. 2011). The base pairing propagates along 
the entire crRNA guided strand and triggers a conformational change of Cse1 
and Cse2, leading to the formation of binding pockets for R-loop stabilization 
(Westra, Nilges et al. 2012, Mulepati, Héroux et al. 2014). In brief, the DNA 
targets recognition process may consist of two steps. In the first step, Cascade 
initiates the non-self-discrimination while scanning and locating the PAM 
sequence of protospacer. In the second step, probably facilitated by 
recognition of PAM (Szczelkun, Tikhomirova et al. 2014), crRNA invades the 
dsDNA by base pairing the seed sequence followed by unwinding of the 
dsDNA and R-loop formation. 
1.4.3.1.3 Cas3-Mediated Target DNA Degradation 
Although the Cascade complex is sufficient for crRNA maturation, 
recognition of DNA targets and R-loop formation, it still cannot accomplish 
the cleavage of invading DNA (Marraffini and Sontheimer 2010). The 
conformational change of Cse1 makes it accessible for the recruitment of Cas3 
for target DNA degradation (Westra, van Erp et al. 2012, Hochstrasser, Taylor 
et al. 2014, Mulepati, Héroux et al. 2014). As the signature protein in Type I 
system, Cas3 plays an essential role during CRISPR interference. As shown in 
 35 
 
Figure 1-5, after engagement with the target DNA, the Cas3 HD nuclease 
domain generates a nick on the non-target DNA strand (Mulepati and Bailey 
2013, Sinkunas, Gasiunas et al. 2013). Subsequently, this nick triggers the 3’ 
to 5’ unwinding of target DNA by Cas3 helicase domain in an ATP-dependent 
manner (Sinkunas, Gasiunas et al. 2011). At the same time, the Cas3 HD 
nuclease domain moves along the non-target strand for exonucleolytic 
degradation (Beloglazova, Petit et al. 2011, Gong, Shin et al. 2014, Huo, Nam 
et al. 2014). It is anticipated that once Cas3 initiates target DNA degradation, 
Cascade is recycled by dissociating from the target DNA and is able to target 
new DNA molecules. 
 
Figure 1-5 DNA interference mechanism of Type I-E system (Adopted 
from Plagens, Richter et al. 2015). 
Subtype I-E is well-studied and is the most representative among Type I 
systems. The schematic model describes the Type I-E Cascade complex 
during target DNA interference. After PAM interrogation by Cse1 subunit, 
crRNA invades the DNA duplex and pairs with the target strand, leading to 
R-loop formation of the non-target strand. Following recruitment of Cas3 
further separates duplex strands and initiates the degradation of non-target 
strand. 
1.4.3.2 Cas9-Mediated Defense Process in Type II 
After the maturation of crRNA, the tracrRNA-crRNA complex, referred 
to as single guide RNA (sgRNA), remains tightly bounded with the Cas9 
protein to form the active surveillance complex (Deltcheva, Chylinski et al. 
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2011, Jinek, Chylinski et al. 2012). Most recently, three groups independently 
determined the crystal structures of S. pyogenes Cas9 in apo form (Jinek, Jiang 
et al. 2014) or in complex with sgRNA and target DNA (Anders, Niewoehner 
et al. 2014, Nishimasu, Ran et al. 2014). These structures provide detailed 
insights into the recognition mechanism of Cas9 with sgRNA and target DNA. 
As shown in Figure 1-6, the structures of SpCas9 protein contains a 
recognition domain (REC), two nuclease domains (HNH and RuvC) and a 
C-terminal domain (CTD).  
1.4.3.2.1 Target DNA Recognition by Cas9-sgRNA  
In the Cas9 protein, the REC domain is involved in both sgRNA 
recognition and binding. REC is a unique domain exclusively found in Cas9 
proteins, and also varies enormously among the Cas9 proteins. Interestingly, 
REC domain shows different recognition strategies towards the guide 
sequence of the sgRNA and tracrRNA-crRNA duplex (Nishimasu, Ran et al. 
2014). The Cas9 REC domain and an RNA recognition motif bind the guide 
sequence of the sgRNA by interacting with the backbone phosphates, rather 
than the nucleobases of the sequence. On the contrary, the REC domain 
directly interacts with the nucleobases within tracrRNA-crRNA duplex region. 
These observations indicate that the recognition of the tracrRNA-crRNA 
duplex is sequence specific while the recognition of the sgRNA guide 
sequence is sequence non-specific. The variation of spacers and the 
conservation of repeat sequence may contribute to the differentiated 
recognition mechanism by Cas9.  
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The screening and targeting of invading DNAs is initiated by the 
Cas9-mediated recognition of the PAM. As mentioned previously, both the 
Type I and Type II systems require PAM to discriminate self and non-self 
DNAs (Deveau, Barrangou et al. 2008, Sapranauskas, Gasiunas et al. 2011, 
Konermann, Brigham et al. 2015) and to bind target DNA for subsequent 
cleavage (Gasiunas, Barrangou et al. 2012, Jinek, Chylinski et al. 2012, 
Sternberg, Redding et al. 2014). As shown by the DNA curtains assay, Cas9 
exclusively binds the target with the presence of a PAM, in despite of the 
sequence of the target (Sternberg, Redding et al. 2014). The CTD is also 
Cas9-specific and is responsible for PAM recognition. In the SpCas9, two 
arginine residues of the conserved DRKRY motif specifically recognize the 
5’-NGG-3’ PAM (Anders, Niewoehner et al. 2014). Interestingly, the PAM 
recognition motif of Cas9 protein correlates with the distinct PAM sequences. 
In the Type II systems recognizing the 5’-NAAAA-3’ PAM, Cas9 proteins 
contain a conserved QLQ motif instead of the RKR motif for PAM 
recognition (Anders, Niewoehner et al. 2014). It is worth noting that CTD 
alone recognizes the PAM and the rational alteration of this domain leads to a 
change of PAM specificities (Deltcheva, Chylinski et al. 2011, Nishimasu, 
Ran et al. 2014). 
Following the PAM recognition, Cas9-sgRNA binds to the DNA target 
and destabilizes the DNA duplex (Figure 1-6). The strand separation is 
initiated to enable the formation of RNA-DNA hetero-duplex (Sternberg, 
Redding et al. 2014). The R-loop formation is accomplished by the local 
melting of the DNA duplex and the DNA-RNA hybridization. After the 
melting of DNA duplex, the guide RNA complements to the seed sequence 
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region of the target DNA sequence (Sternberg, Redding et al. 2014, Szczelkun, 
Tikhomirova et al. 2014). The seed region of the guide RNA are exposed to 
the solvent, probably facilitated by the interaction between the phosphate 
backbone and REC domain as well as RNA recognition motif (Nishimasu, 
Ran et al. 2014). This conformation leads to the easy access of the seed region 
for the nucleation of hetero-duplex formation. The matching within the seed 
sequence region is highly required for initial R-loop formation and sequential 
propagation along the target DNA (Szczelkun, Tikhomirova et al. 2014).  
1.4.3.2.2 Cas9-Mediated DNA Cleavage 
In contrast to the Type I systems in which Cascade complex stabilizes the 
R-loop and recruits Cas3 for cleavage, Cas9 alone is responsible for the 
stabilization of the R-loop and the cleaving of target DNA (Figure 1-6). In 
Cas9 protein, both nuclease domains RuvC and HNH are involved in target 
cleavage (Anders, Niewoehner et al. 2014, Jinek, Jiang et al. 2014, Nishimasu, 
Ran et al. 2014).  
 
Figure 1-6 DNA interference mechanism of Type II system (Adopted from 
Plagens, Richter et al. 2015).  
The schematic structures of apo and sgRNA-dsDNA bound Cas9 represent 
inactive and active states, respectively. The binding of tracrRNA and crRNA 
induces the conformational change of Cas9, and guides Cas9 to the target 
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DNA.  After PAM interrogation, the guide sequence of crRNA sequentially 
complements with target DNA, which initiates the cleavage of both target and 
non-target strand by HNH and RuvC nuclease domains, respectively. 
The sgRNA and dsDNA form a T-shaped structure in the 
Cas9-sgRNA-DNA ternary complex, in which the DNA-RNA hetero-duplex 
is anchored in the major groove shaped by HNH and REC domains 
(Nishimasu, Ran et al. 2014). In contrast to the structures of 
Cas9-sgRNA-DNA ternary complex (Anders, Niewoehner et al. 2014, 
Nishimasu, Ran et al. 2014), the apo structure harbors a disordered HNH 
domain (Jinek, Jiang et al. 2014). These observations suggest that the 
conformational change of HNH domain is induced by the binding of sgRNA 
or sgRNA-DNA (Figure 1-6). The structural comparison also reveals the 
conformational change of REC domain, which may facilitate the binding of 
the target DNA by the positive-charged channel of REC domain (Anders, 
Niewoehner et al. 2014, Nishimasu, Ran et al. 2014). The assembly of ternary 
complex and the following structural rearrangements yield an activated Cas9 
protein for DNA cleavage (Figure 1-6).  
The cleavage of target and non-target strand is accomplished by HNH 
and RuvC nuclease domains, respectively (Sapranauskas, Gasiunas et al. 2011, 
Gasiunas, Barrangou et al. 2012, Jinek, Chylinski et al. 2012). Although both 
domains show endoribonuclease activity, the two nucleases employ different 
catalytic mechanisms. On one hand, the HNH domain harbors a catalytic triad 
composed of an aspartate, an asparagine and a histidine residue. These three 
residues coordinate with one Mg2+ ion and function as the active site of the 
HNH domain. On the other hand, the RuvC domain has four catalytic residues 
including two aspartates, a glutamate and a histidine residue. In contrast to the 
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single-metal mechanism employed by the HNH domain, the RuvC domain 
employs a two-metal mechanism. In the active site of the RuvC domain, two 
Mg2+ ions are coordinated by the four catalytic residues (Jinek, Jiang et al. 
2014, Nishimasu, Ran et al. 2014).  
Additionally, the two domains also share a similarity that both cleavage 
sites exactly locate at 3 nt immediately upstream of the PAM (Gasiunas, 
Barrangou et al. 2012, Jinek, Chylinski et al. 2012). As a consequence, the 
double-strand break within the protospacer yields two blunt-ended dsDNA 
products (Sapranauskas, Gasiunas et al. 2011, Gasiunas, Barrangou et al. 2012, 
Jinek, Chylinski et al. 2012). After cleavage, Cas9 does not disassociate with 
the targeted DNA, indicating that Cas9 is a single turnover enzyme (Sternberg, 
Redding et al. 2014).  
 
Figure 1-7 RNA interference mechanism of Type III systems (Adopted 
from Plagens, Richter et al. 2015). 
The schematic model of Type III-A Csm complex from S. Solfataricus (A) 
and Type III-B Cmr complex from P. furiosus (B). They both share similar 
architecture and interference mechanism against target RNA. Instead of PAM 
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interrogation, Type III surveillance complexes distinguish self and nonself by 
the paired/unpaired 5’ handle region of crRNA. The backbone protein 
Csm3/Cmr4 is responsible for multiple cleavage of target RNA with 6 nt 
intervals. 
1.4.3.3 Defense Mechanisms in Type III Systems 
Similar to Type I Cascade, the Type III surveillance complexes are also 
formed with mature crRNAs and multiple subtype-specific proteins. Although 
the protein subunits are phylogenetically distinct, the surveillance complexes 
shares similar architectures among the Type I and Type III systems (Rouillon, 
Zhou et al. 2013, Spilman, Cocozaki et al. 2013, Staals, Agari et al. 2013).  
1.4.3.3.1 Csm-Mediated Defense Process in Type III-A  
Type III-A subtypes have been demonstrated to target both DNA 
(Marraffini and Sontheimer 2008) and complementary ssRNA (Staals, Zhu et 
al. 2014, Tamulaitis, Kazlauskiene et al. 2014). The structures of two Type 
III-A Csm complexes have been determined by electron microscopy (Rouillon, 
Zhou et al. 2013, Staals, Zhu et al. 2014). Although the molecular weight of 
both complexes are nearly identical (~427 or ~428 kDa), the protein 
composition and stoichiometry greatly differ from each other. 
1.4.3.3.1.1 The Type III-A Interference Complex  
As shown in Figure 1-7A, the Csm complex from S. solfataricus is 
composed of Csm1, Csm2, Csm3, and Csm4 with the stoichiometry of 1:3:8:1 
and one crRNA a length of ~50 nt (Rouillon, Zhou et al. 2013). Interestingly, 
five individual Csm3-encoding genes (Sso1425-1427, Sso1430 and Sso1432) 
co-occur in the Cas locus, namely Csm3.1 to Csm3.5. The relative molar ratio 
of five different Csm3 subunits was assigned as 1:4:1:1:1 in the complex 
(Figure 1-7A). Csm3 has shown structural similarity to Cas7 and is regarded 
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as a Cas7-family RAMP domain protein (Hrle, Su et al. 2013). Similar to the 
Cascade backbone composed of multiple Cas7 subunits, the helical 
crRNA-binding backbone of Csm complex is composed of four copies of 
Csm3.2 and one Csm3.3 subunit (Rouillon, Zhou et al. 2013). In this case, the 
Csm1-Csm4 interacts with Csm3.3 at one end of the backbone and binds the 
5’ handle of the crRNA. Another end of the backbone is capped by the 
Csm3.1and Csm3.5 subunits, both presumably bound to the 3’ handle of the 
crRNA. In addition, three copies of Csm2 comprise a second helical filament 
intertwined with the main backbone and contact the Csm1 through the Csm3.4 
subunit (Figure 1-7A).  
The Csm complex from T. thermophilus is composed of Csm1, Csm2, 
Csm3, Csm4 and an additional Csm5 with the proposed stoichiometry of 
1:3:6:2:1 and one crRNA (Staals, Zhu et al. 2014). The crRNAs with variable 
lengths ranging from 35 to 53 nt were co-purified with Csm complex. 
Similarly, the crRNA-binding backbone is formed by six copies of Csm3 
which is encoded by a single gene. In this case, the Csm1 and two Csm4 
subunits interact with Csm3 at one end of the backbone and bind the 5’ handle 
of the crRNA. Another end of the backbone is capped by the Csm5 subunit, 
presumably bound to the 3’ handle of the crRNA. Same with SsCsm complex, 
TtCsm complex also contains three copies of Csm2 comprising a second 
helical filament intertwined with the main backbone.  
1.4.3.3.1.2 Csm-Mediated Defense Mechanisms 
After the maturation of crRNA and complex assembly, the Csm 
interference complex is activated to target invading nucleic acids for cleavage. 
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Similar to Type I systems, previous findings revealed that DNA is the target of 
Csm complex (Marraffini and Sontheimer 2008). It is shown that 
Staphylococcus epidermidis employs Type III-A system to prevent plasmid 
transformation and conjugation by a DNA-targeting mechanism. However, so 
far, Csm complex has not been demonstrated to show cleavage activity against 
target DNA in vitro (Marraffini and Sontheimer 2010, Rouillon, Zhou et al. 
2013).  
Meanwhile, it is observed the Csm complex is able to cleave 
complementary target ssRNAs both in vivo and in vitro (Staals, Zhu et al. 
2014, Tamulaitis, Kazlauskiene et al. 2014). It is shown that multiple cuts 
occur along the target RNA, generating multiple degradation products with 6 
nt difference in size (Figure 1-7A). The Csm complex with mutant Csm3 
subunits showed no RNA cleavage activity, demonstrating that Csm3 subunit 
acts as the endoribonuclease (Tamulaitis, Kazlauskiene et al. 2014). Consistent 
with Csm-mediated RNA cleavage, DNA targeting in S. epidermidis is 
mediated by Type III-A system in a transcription-dependent manner 
(Goldberg, Jiang et al. 2014). It is suggested that the hosts prevent virus 
assembly and lytic infection by interfering with the transcripts of phages while 
at the same time, the lysogenization by phages is tolerated.  
The recognition mechanism remains elusive in Type III system. In 
contrast to PAM-dependent target recognition in Type I and II systems, Type 
III systems show no dependence on PAM sequences during interference 
(Staals, Zhu et al. 2014, Tamulaitis, Kazlauskiene et al. 2014). Instead, the 
conserved 8 nt 5’ handle of the crRNA generated by the Cas6-mediated 
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cleavage has been proposed to be involved in the discrimination between self 
and non-self DNA (Figure 1-7A). The autoimmune interference might be 
blocked due to the base pairing of the 5’ handle region and host DNA 
(Marraffini and Sontheimer 2010). In this hypothesis, the unpaired 5’ handle 
allows the propagation of complementation between the crRNA and target, 
while the duplex formation in 5’ handle region inhibits further complement 
along crRNA. According to the EM structure, the 5’ handle is anchored in the 
boundary of Csm4 and the large subunit Csm1, indicating that Csm1 may be 
involved in target recognition and discrimination (Rouillon, Zhou et al. 2013, 
Staals, Zhu et al. 2014).  
1.4.3.3.2 Cmr-Mediated Defense Process in Type III-B 
Similar to Type III-A subtypes, Type III-B subtypes have also been 
demonstrated to target both the DNA (Deng, Garrett et al. 2013, Peng, Feng et 
al. 2015), as well as complementary RNA (Hale, Zhao et al. 2009, Staals, 
Agari et al. 2013, Zebec, Manica et al. 2014). The structures of the T. 
thermophilus Cmr and P. furiosus Cmr complexes have been determined by 
electron microscopy at the resolution of ~17 Å and ~12 Å, respectively 
(Spilman, Cocozaki et al. 2013, Staals, Agari et al. 2013). These structures 
have revealed the general profile and structural compositions of the Cmr 
complexes. Furthermore, the near-atomic Cryo-EM structures of the TtCmr 
complex have been determined (Taylor, Zhu et al. 2015) and a pseudo-atomic 
model of the PfCmr complex is constructed (Benda, Ebert et al. 2014), 
providing more insights into the molecular basis of protein assembly, crRNA 
interaction, as well as target recognition and cleavage. 
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1.4.3.3.2.1 The Type III-B Interference Complex  
The TtCmr complex consists of Cmr1, Cmr2, Cmr3, Cmr4, Cmr5 and 
Cmr6 with the stoichiometry of 1:1:1:4:3:1 and one crRNA in length of 40 or 
46 nt (Staals, Agari et al. 2013, Taylor, Zhu et al. 2015). The molecular weight 
of the Cmr complex is ~350 kDa. Generally, four Cmr4 and three Cmr5 
subunits comprise the central helical backbone capped by Cmr1 and Cmr6 at 
one end and a Cmr2-Cmr3 heterodimer at the other. Cmr2 is also shown to 
contact with one Cmr5 subunit by an α-helical bundle (Taylor, Zhu et al. 
2015). The Cmr2-Cmr3 heterodimer interacts with the 5’ handle of the crRNA, 
while Cmr1-Cmr6 binds the 3’ handle of the crRNA (Staals, Agari et al. 2013, 
Taylor, Zhu et al. 2015). In addition to the intact apo Cmr complex, the 
structure of a target-bound Cmr complex has also been determined (Taylor, 
Zhu et al. 2015). The alignment between apo and target-bound Cmr structures 
reveals structural rearrangement of several subunits except for the Cmr4 
backbone. The Cmr1 and Cmr2 subunits undergo a minor conformational 
change with a small-angled rotation, yet the related mechanism is unknown. It 
is worth noting that the Cmr5 homotrimer is pushed away from the Cmr4 
backbone, leading to the exposure of the crRNA for the formation of the 
crRNA-target ssRNA duplex.  
The PfCmr complex also contains six Cmr subunits with a proposed 
stoichiometry of 1:1:1:3:3:1 based on the interpretation of EM structure 
(Spilman, Cocozaki et al. 2013). Due to the lack of available structures of 
subunits, assignment of protein subunits is roughly accomplished by fitting the 
crystal structures of the Cmr2-Cmr3 (Shao, Cocozaki et al. 2013) and Cmr5 
(Park, Sun et al. 2013) and the helical Cmr4-Cmr5 filament structure into the 
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cryo-EM map of the intact Cmr complex. The other subunits are assigned 
according to the differentiated EM density in the presence or absence of 
subunits (Spilman, Cocozaki et al. 2013). A follow-up study reported the 
crystal structures of Cmr1, Cmr2, Cmr4, and Cmr6 from P. furiosus (Benda, 
Ebert et al. 2014). In addition, to deduce the accurate position and orientation 
of each subunit in the complex, chemical crosslinking and mass spectrometry 
was applied to identify specific inter-subunit restraints. In combination of the 
structures of all six subunits and the cryo-EM map of PfCmr complex, a 
pseudo-atomic model of the PfCmr complex is constructed (Benda, Ebert et al. 
2014). Although three copies of Cmr4 has been proposed to be present in the 
PfCmr complex (Spilman, Cocozaki et al. 2013), four copies of Cmr4 are 
fitted in the EM map so as to avoid an unexplained extra density (Benda, Ebert 
et al. 2014). As shown in Figure 1-7B, the protein stoichiometry in the model 
of PfCmr complex is proposed to be 1:1:1:4:3:1, consistent with the 
stoichiometry in TtCmr complex (Staals, Agari et al. 2013, Taylor, Zhu et al. 
2015).  
Distinct from all the Cmr complexes mentioned above, an additional 
Cmr7 is proposed to be an integral subunit of the Cmr complex and the 
proposed stoichiometry of seven Cmr subunits is 1:1:1:1:1:1:6 in S. 
solfataricus (Zhang, Rouillon et al. 2012).  
1.4.3.3.2.2 Cmr-Mediated Defense Mechanisms 
The PfCmr complex is shown to cleave complementary RNAs at 14 nt 
upstream of the 3’ end of the crRNA in vivo and in vitro (Hale, Zhao et al. 
2009, Hale, Majumdar et al. 2012). As observed in PfCmr complex model, it 
is suggests that nuclease active site is in the vicinity of a Cmr4 subunit which 
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shields the indicated cleavage site of the target RNAs (Hale, Zhao et al. 2009, 
Hale, Majumdar et al. 2012, Benda, Ebert et al. 2014). The Cmr4-mediated 
target RNA cleavage is supported by the in vitro cleavage assays using Cmr 
complexes containing mutant Cmr4 (Benda, Ebert et al. 2014, Ramia, Spilman 
et al. 2014, Zhu and Ye 2015). Accordingly, multiple copies of Cmr4 lead to 
multiple cleavage along the target RNA with a distance of 6 nt corresponding 
to the distance of active sites between two neighboring Cmr4 subunits (Figure 
1-7B). In addition, TtCmr complex is shown to display processive cleavage of 
the target RNA in the 3’ to 5’ direction (Staals, Agari et al. 2013).  
Interestingly, it has also been demonstrated that one of the Cmr 
complexes (Cmr-α and Cmr-β) could target both RNA and DNA in Sulfolobus 
islandicus (Deng, Garrett et al. 2013, Peng, Feng et al. 2015). The Cmr-α 
complex is composed of Cmr1-6 and is shown to target plasmid DNA in the 
presence of Csx1 (Deng, Garrett et al. 2013). Moreover, Cmr-α-mediated 
interference requires antisense transcript of the protospacer, similar to the 
transcription-dependent activities of the Type IIIA interference (Deng, Garrett 
et al. 2013, Goldberg, Jiang et al. 2014). Nevertheless, the substantially 
distinct mechanisms suggest a much more diverse interference process in the 
Type III systems.  
Similar to the proposed targeting mechanism in Type III-A system, the 5’ 
handle of the crRNA is necessary for crRNA interference by Cmr complexes 
(Hale, Majumdar et al. 2012, Zhang, Rouillon et al. 2012, Zhu and Ye 2015). 
According to the EM structure, the 5’ handle is anchored in the boundary of 
Cmr3 and the large subunit Cmr2, which might be involved in target 
recognition (Benda, Ebert et al. 2014, Taylor, Zhu et al. 2015). 
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1.5 The Application of CRISPR/Cas Systems 
In addition to the scientific interest in elucidating this novel immune 
system, the applications of the CRISPR/Cas systems have been proposed in 
several distinct areas. The two well-established applications are discussed as 
follow.  
One application is to develop phage-resistant strains for the industrial 
fermentation. As is known, the microorganisms used for fermentation are 
occasionally impaired by lytic phages. Taking advantage of the adaptive 
property of CRISPR/Cas systems, strains with a broader spectrum of 
resistance can be generated with the accumulation of new spacers during the 
iterative challenges of multiple phages (Labrie, Samson et al. 2010). Even for 
those strains which do not possess CRISPR/Cas systems, the introduction of 
CRISPR/Cas systems may also allow the acquisition of spacers and improve 
the phage-resistant efficiency (Sapranauskas, Gasiunas et al. 2011). 
In addition, another prevalent application is to use engineered Cas9 
CRISPR/Cas system for genomic manipulation and transcriptional regulation. 
At present, a wide variation of genetic modifications can be accomplished by 
several powerful tools, such zinc-finger nucleases (ZFNs) and transcription 
activator-like effector nucleases (TALENs) (Gaj, Gersbach et al. 2013). Both 
ZFNs and TALENs rely on rational engineered enzymes which limit the 
recognition of new sequences. In contrast, the Cas9 CRISPR/Cas system 
depends on the specificity of sgRNA which can be easily modified for the 
targeting of any sequence. Currently, targeting specific gene for mutation or 
insertion/deletion has been developed in bacteria, yeast, plant and mammalian 
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cells (Cong, Ran et al. 2013, DiCarlo, Norville et al. 2013, Jiang, Bikard et al. 
2013, Belhaj, Chaparro-Garcia et al. 2015). Furthermore, nuclease-inactivated 
Cas9 fused with transcription factor proteins may allow genome-scale 
transcriptional regulation (Konermann, Brigham et al. 2015). 
1.6 CRISPR-associated Csx3 in A. fulgidus  
The hyperthermophilic archaea A. fulgidus DSM 4304 possesses three 
CRISPR loci and at least 20 putative cas genes (Rousseau, Gonnet et al. 2009). 
In A. fulgidus, both Type I-A and III-B systems coexist in one CRISPR locus. 
One complete gene cluster, including cas1-6, cmr1-6, csa1, csa2, csa3, csa5 
and csx3, is associated with CRISPR 3 locus (Figure 1-8). According to the 
CRISPI database, the repeat in CRISPR 3 locus is 37 nt, and the length of 
spacers varies from 34 to 41 nt. 
 
Figure 1-8 The schematic arrangement of Cas proteins in CRISPR/Cas 
locus of A. fulgidus (Adopted from Daniel H. Haft 2005).  
Both Type I-A and III-B systems coexist in one CRISPR locus and share the 
same set of proteins for acquisition and crRNA processing. AfCsx3-encoding 
gene locates between cmr3 and cmr4 within the III-B gene cluster. 
In addition to the classical Cas proteins in Type I-A and III-B systems, an 
AfCsx3-encoding gene AF1864 is found to locate between cmr3 and cmr4 
within the gene cluster (Figure 1-8). The nomenclature csx indicates an 
unclassified gene family which is not characterized in sufficient detail 
(Makarova, Haft et al. 2011). To date, the csx3 genes have been found to be 
adjacent to well-characterized Type III systems in both bacteria and archaea 
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species. So far, Csx3 is not included in any classical Cas protein families due 
to the lack of identifiable contextual patterns and the fact that its function is 
largely unknown (Haft, Selengut et al. 2005, Makarova, Haft et al. 2011). 
1.7 Research Aims and Significance 
1.7.1 Research Aims  
To date, AfCsx3 remains largely unknown on the structures and 
biochemical functions. To gain insight into the molecular function of AfCsx3, 
the purpose of this study is to determine the crystal structures of AfCsx3 in 
free, manganese- and RNA-bound forms, and explore its structural and 
biochemical properties based on the three-dimensional structures. The specific 
aims of this thesis are to:  
 Solve the crystal structures of AfCsx3 by X ray crystallography, 
 Describe the overall atomic three-dimensional structure, 
 Identify RNA binding ability and residues involved in RNA 
recognition by mutagenesis and EMSA, 
 Decipher RNA cleavage mechanism and identify catalytic residues by 
mutagenesis and in vitro cleavage assay  
 Characterize the biological role of AfCsx3 in vitro and 
 Verify the role of AfCsx3 in the CRISPR/Cas immune system. 
1.7.2 Research Significance  
In despite of all the efforts made previously, the structural and functional 
aspects of many Cas proteins remain unclear. In addition to the classical Cas 
proteins, there are a series of CRISPR-associated Csx proteins which are 
unidentified and regarded to be not-so-important. However, a previous study 
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has demonstrated that Csx1 protein somehow functions in the defense process 
(Deng, Garrett et al. 2013). A Csx1-encoding gene is found to co-locate with 
cmr gene locus in some species and the complementation with Csx1 protein 
restores interference activity of the csx1-deleted mutant (Deng, Garrett et al. 
2013). Therefore, we hypothesize that each Cas protein may serve an 
indispensable role in the CRISPR/Cas immune system. Hence, deciphering the 
role and structure of specific Cas proteins is fundamental for a more 
comprehensive understanding of the mechanism of the CRISPR/Cas immune 
system. Among those Cas proteins, Csx3 is a non-characterized novel Cas 
protein and it is exclusively found in Type III system. Interestingly, the 
AfCsx3-encoding gene AF1864 is located between cmr3 and cmr4 in the gene 
cluster, suggesting that AfCsx3 may be functionally related to the CRISPR/Cas 
immune defense process. The results of the structure knowledge of 
superfamily Csx3 should shed light on crystal structures that are not available 
so far. Structural investigation of AfCsx3 protein should be useful for research 
on the biochemical functions of AfCsx3, such as RNA recognition and 
manganese-dependent deadenylase activity. This information could also be 
useful for further investigation of the biological function of AfCsx3 in the 





CHAPTER 2 Materials and Methods 
In this chapter, the detailed description of methods will be presented, 
including molecule cloning, protein expression and crystallization, structure 
determination as well as relative biochemical and functional assays conducted 
in vitro. 
2.1 Sequence alignment 
Based on the blast-search against UniProt Knowledgebase 
(http://www.uniprot.org), AfCsx3, together with other 46 proteins, is classified 
as the Csx3_III-U homolog proteins. These proteins share relatively low 
sequence similarities, which are varied from 27% to 58%. The top 14 
homologues were obtained from UniProt Knowledgebase and the sequences of 
the Csx3 homologues were aligned by DNAMAN 
(http://www.lynnon.com/dnaman.html). The aligned sequences 
(SWISS-PROT ID) are as follows: Y1864_ARCFU (Archaeoglobus fulgidus), 
Y377_AQUAE (Aquifex aeolicus), F8AJ05_PYRYC (Pyrococcus yayanosii), 
I3ZWS0_9EURY (Thermococcus sp. CL1), B5YBJ8_DICT6 (Dictyoglomus 
thermophilum), B8DZG8_DICTD (Dictyoglomus turgidum), 
D9S1M9_THEOJ (Thermosediminibacter oceani), D3S350_FERPA 
(Ferroglobus placidus), K8GEC4_9CYAN (Oscillatoriales cyanobacterium 
JSC-12), W6SD50_9CYAN (Arthrospira sp.), Q2JVY5_SYNJA 
(Synechococcus sp.), K1W731_ARTPT (Arthrospira platensis C1), 
A0ZJA1_NODSP (Nodularia spumigena CCY9414), A0YT15_LYNSP 
(Lyngbya sp.) and I0JXU5_9BACT (Methylacidiphilum fumariolicum SolV). 
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2.2 Cloning, Protein Expression and Purification 
2.2.1 Gene Cloning 
The AfCsx3-encoding gene AF1864 was amplified by polymerase chain 
reaction (PCR) using the genomic DNA of A. fulgidus DSM 4304 as template. 
The PCR fragment was digested and ligated into the NheI/XhoI restriction 
sites of expression vector pET28-b (Novagen), which provides a 
hexa-histidine tag at the N-terminus of the recombinant protein. The ligation 
product was sequentially transformed into E. coli DH5 competent cells for 
positive colony selection. After identified by both colony PCR and double 
digestion, the constructs were further verified by DNA sequencing.  
2.2.2 Site-directed mutagenesis 
AfCsx3 mutants are generated by alanine scanning mutagenesis of the 
critical residues may be involved in RNA recognition (R46A, R71A, 
R46A/R71A, K20A/K23A and K23A/R84A), manganese ion coordination 
(H57A, K58A, H60A, H80A, K85A, H57A/K58A, H57A/K85A, K58A/K85A, 
H57A/K58A/K85A and H60A/H80A), and dimer formation 
(W50A/H52A/C53A/H57A). Due to the lack of methionine residues, the 
mutant I49M/L51M, also named as AfCsx3 thereafter, was generated for 
selenium-substituted AfCsx3 production in E. coli. The mutant constructs were 
generated using PCR-driven overlapping mutagenesis method and verified by 
DNA sequencing (Table S-1). The DNA oligonucleotides used for plasmid 





Table 2-1: DNA oligonucleotides used for plasmid construction 
ID Sequence (5’-3’) 
Csx3-NheI-F CTAGCTAGCATGAAATTCGCTGTGATTGA 
Csx3-XhoI-R CCGCTCGAGTCAAACATGTCGAACACCTC  
R46A-F ATCTCTGGAGCAGGTCCAATA 























I49M/L51M -F CTAGCTAGCATGAAATTCGCTGTGATTGA 








2.2.3 Protein expression  
The constructed plasmid was transformed into E. coli BL21/DE3 
competent cells using a heat-shock method. The transformed cells were 
cultured in LB medium at 37 °C. Grown to an OD600 of ~0.8, the cells were 
induced with 0.4 mM isopropyl-β-D-thiogalactopyranoside (IPTG) and were 
cultured at 20°C overnight. Selenium-substituted AfCsx3 protein was prepared 
as described previously (Doublié 1997). Briefly, the transformed cells were 
cultured in M9 medium at 37 °C. Grown to an OD600 of ~0.8, the M9 
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medium was compensated with amino acids mixture with selenomethionine 
instead of methionine. Incubated for another half an hour, the cells were 
induced with 0.4 mM IPTG and cultured at 20°C overnight. 
2.2.4 Protein purification  
Cells were harvested by mild centrifugation and the pellets were 
re-suspended in lysis buffer (20 mM Tris-HCl pH 7.5, 500 mM NaCl and 10% 
glycerol) with 0.2 mM phenylmethylsulfonyl fluoride. The cells were 
disrupted by passing through high pressure homogenizer (www.avestin.com) 
three times. The lysate was then centrifuged at the speed of 35,000 rpm 
(Beckman, Rotor Type 45 Ti) for 1 h to remove insoluble cell debris. The 
supernatant was applied onto Ni–NTA affinity column and washed 
sequentially with elution buffer containing increasing concentrations of 
imidazole. The AfCsx3 protein was mostly eluted at the concentration of 
500mM imidazole. After the imidazole was removed by dialysis in the lysis 
buffer, the protein solution was again passed through the Ni-NTA column and 
eluted as previously mentioned. After the two-step purification, the purity of 
AfCsx3 protein was confirmed by SDS-PAGE. Due to unexpected 
circumstances, AfCsx3 protein showed weak stability and easily precipitated at 
higher concentration, while the addition of 500 mM imidazole may help 
maintain the stability. Therefore, the protein was resolved in a buffer solution 
containing 20 mM Tris-HCl (pH 7.5), 125 mM NaCl，5% (v/v) Glycerol and 
500 mM imidazole and then concentrated to ~15 mg/ml for subsequent 
crystallization. Protein concentration was measured according to a BSA 
standard curve constructed by using the Bradford reagent (Bio-Rad). 
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2.3 Crystallization screening and optimization  
Initial crystallization screening was performed by using commercial kits 
from Hampton Research, Crystalgen and Qiagen (Table S-2). Once primary 
crystals were observed, further optimization strategies were performed to 
obtain crystals with high quality. Crystals of selenium-substituted AfCsx3 
were grown at 20 ˚C by mixture of 1.0 μl of protein with 1.0 μl of reservoir 
containing 100 mM Citrate/Phosphate (pH 4.0) and 2 M Ammonium sulfate. 
These crystals grew to a maximal size of 0.1 mm × 0.1 mm × 0.3 mm over the 
course of 10 days. The crystals of AfCsx3 in complex of manganese were 
prepared by soaking selenium-substituted AfCsx3 crystals with 1 mM 
manganese chloride overnight. Native AfCsx3 was mixed with repeat ssRNA 
at a ratio of 1:1.1 and subjected for crystallization. The crystals of 
AfCsx3-ssRNA complex were grown at 20 ˚C by mixture of 1.0 μl of 
AfCsx3-ssRNA with 1.0 μl of reservoir containing 20 mM magnesium 
chloride, 100 mM Hepes (pH 7.5) and 1.5 M lithium sulfate.  
2.4 Structure determination  
The crystals were flash frozen (100 K) in the reservoir solution 
supplemented with 30% (v/v) glycerol. One-wavelength data set (total 360˚ 
with 1˚ oscillation) for AfCsx3 in free form was collected at the wavelength of 
0.9792 Å on beamline U17 at Shanghai Synchrotron Radiation Facility 
(BL17U, SSRF), whereas the data set for AfCsx3 in complex with ssRNA was 
collected at the wavelength of 1.075 Å on beamline X29A at the National 
Synchrotron Light Source of Brookhaven National Laboratory (X29A, NSLS).  
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The data set for AfCsx3 in complex with manganese was collected at the 
wavelength of 1.5418 Å using an in-house RIGAKU RU-200 X-Ray 
Generator. All data sets were processed by HKL2000 (Otwinowski and Minor 
1997). The structure of AfCsx3 in free form was determined by single 
wavelength anomalous diffraction (SAD) method using SHARP/autoSHARP, 
whereas the structures of AfCsx3 in complex with manganese and ssRNA 
were determined by difference fourier electron density map and molecular 
replacement (Molrep/CCP4, www.ccp4.ac.uk), respectively. The models were 
built using the program O (Jones, Zou et al. 1991) and refined using 
REFMAC/CCP4 (Collaborative Computational Project 1994). The coordinate 
has been deposited in the Protein Data Bank under the accession codes 3WZG 
(AfCsx3 in free form), 3WZH (AfCsx3 in complex with manganese) and 3WZI 
(AfCsx3 in complex with ssRNA). 
Table 2-2: DNA oligonucleotides used for in vitro transcription 
 
 ID Sequence (5’-3’) 
A7-T7-F TAATACGACTCACTATAGGGAAAAGAAAAAAA 
A7-T7-R TTTTTTTCTTTTCCCTATAGTGAGTCGTATTA  
A10-T7-F TAATACGACTCACTATAGGGAAAAGAAAAAAAAAA 
A10-T7-R TTTTTTTTTTCTTTTCCCTATAGTGAGTCGTATTA  
A6C-T7-F TAATACGACTCACTATAGGGAAAAGAAAAAAC  
A6C-T7-R GTTTTTTCTTTTCCCTATAGTGAGTCGTATTA  
A6G-T7-F TAATACGACTCACTATAGGGAAAAGAAAAAAG  
A6G-T7-R CTTTTTTCTTTTCCCTATAGTGAGTCGTATTA  
A6U-T7-F TAATACGACTCACTATAGGGAAAAGAAAAAAT  
A6U-T7-R ATTTTTTCTTTTCCCTATAGTGAGTCGTATTA  
 
2.5 Preparation of ssRNAs 
RNA oligos (A7, A10, A6C, A6U, A6G and Oligo A) were generated by 
in vitro transcription using T7 RiboMAX™ Express Large Scale RNA 
Production System (Promega). All the procedures are followed by the 
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manufacturer’s instructions. Transcription templates were prepared by 
annealing two complementary oligonucleotides with a T7 promoter at 
5’-terminus of RNA-encoded sequence. Transcription reactions were 
incubated at 37°C for 4 hours and the RNA products were size-fractioned on a 
20% polyacrylamide gel containing 8 M urea. Subsequently, the target bands 
of RNA products were excised from the gel and soaked in the elution buffer 
(0.3 M NaAc and 0.1% SDS) at 42 °C overnight. The RNAs were extracted by 
TRIZOL and precipitated by isopropanol. After washed twice by 75% 
ice-cooled ethanol, the RNAs were dissolved in DEPC-treated water. The 
DNA oligonucleotides used for in vitro transcription are listed in Table 2-2. 
The ssRNAs (Af repeat, Ct repeat, Pf repeat and Tf repeat) are derived 
from consensus repeat sequences of A. fulgidus CRISPR 3, Clostridium 
thermocellum CRISPR 2, P. furiosus CRISPR 3 and Thermobifida fusca 
CRISPR 6, respectively (Rousseau, Gonnet et al. 2009). The repeat RNAs and 
an unrelated RNA were purchased from Research Dharmacon 
(http://dharmacon.gelifesciences.com). RNA oligos (Oligo C, Oligo U and 
Oligo G) were purchased from Integrated DNA Technologies 
(http://sg.idtdna.com). The RNA oligonucleotides used for EMSA and 
nuclease assays are listed in Table 2-3. 
Table 2-3: RNA oligonucleotides used for EMSA and nuclease assays 
 
ID Sequence (5’-3’) 
Af repeat  GUAAGAAAGGGAGGCUCCUGAAAAUGGAGAUUGAAAG 
Ct repeat  GUUUUUAUCGUACCUAUGAGGAAUUGAAAC  
Pf repeat  CUUUCAAUUCUAUUUUGGUCUUAUUGUAAC  
Tf repeat  GAGAGCCCCACGCACGTGGGGATGGACCG  
Unrelated  GGUCCCAAGGGUAUGGCUGUUCGCCAUUU  
A7 GGGAAAAGAAAAAAA  
A10 GGGAAAAGAAAAAAAAAA  
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A6C GGGAAAAGAAAAAAC  
A6G GGGAAAAGAAAAAAG  
A6U GGGAAAAGAAAAAAU  
Oligo A GGGGAAAAAAAAAA  
Oligo G GGGAAAAGGGGGGG  
Oligo C GGGAAAAGCCCCCC  
Oligo U GGGAAAAGUUUUUU  
 
2.6 Electrophoretic mobility shift assay (EMSA) 
To detect nucleic acid binding ability of AfCsx3, EMSA was performed 
using increasing amount of wild-type protein and several nucleic acid 
substrates. The nucleic acids and protein were incubated in buffer solution 
containing 200 mM KCl, 10% (v/v) Glycerol, 20 mM Hepes (pH7.0) and 1 
mM EDTA. The mixture at a total volume of 10 μl was loaded onto a 12 % 
native polyacrylamide gel, and electrophoresis was conducted at 120 V for 1.5 
h at 4 °C. The binding ability of protein mutants was detected the same as the 
wild-type protein using EMSA. SYBR Gold staining was used to detect 
nucleic acids, followed by the coomassie blue staining for proteins detection. 
The gel was visualized and analyzed by Genesnap software.  
2.7 Cleavage assay 
The nucleic acid and AfCsx3 protein were incubated in buffer solution 
containing 200 mM KCl, 10% (v/v) Glycerol, 20 mM Hepes (pH 7.0) with or 
without 20 mM divalent cations. Cleavage assays were performed using 20 
μM protein and 10 μM substrate. All reactions were conducted at 55 °C for 30 
min, unless otherwise stated, and terminated by addition of formamide RNA 
loading buffer (90% formamide, 0.5 mM EDTA pH 8.0, 0.025% SDS, 0.025% 
Xylene Cyanol and 0.025% Bromophenol Blue). The RNA ladder was 
generated by limited alkaline hydrolysis of a 14 nt RNA oligo. RNA oligo was 
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incubated in 50 mM NaHCO3 (pH 8.0) at 100°C for 1hr and neutralized with 
300 mM NaAc (pH 5.0). The RNA samples were resolved by 20% 
polyacrylamide gel containing 8 M urea. The gel was visualized by SYBR 
Gold staining and analyzed by Genesnap software. 
2.8 Enzyme kinetic assays 
To identify the enzyme kinetic properties of AfCsx3, catalytic parameters 
were tested and the cleavage efficiency was measured accordingly. The 
concentration of protein was reduced to 5 μM per reaction, so that the reaction 
may not be finished in short period. Three parameters were tested, including 
temperature, ion concentration and pH value. Each assay was performed with 
variation of one parameter while the other two are the same as cleavage assay 
mentioned above. The temperature is ranged from 20 to 60°C with 5°C 
intervals. The ion concentration is set as 0.001, 0.01, 0.1, 1, 5, 10 and 20 mM. 
The pH value is ranged from 5 to 9 with 0.5 intervals. The nucleic acid and 
AfCsx3 protein were incubated for 30 min and terminated by addition of 
formamide RNA loading buffer. The RNA samples were resolved by 20% 
polyacrylamide gel containing 8 M urea. The gel was visualized by SYBR 
Gold staining and analyzed by Genesnap software. The intensity of substrate 
and product bands was extracted and the relative curves were made by 
OriginPro 9.1. Each experiment was performed three times and the standard 
derivation was used as error bar. 
2.9 Small RNA library construction, sequencing and analysis 
The protocols for RNA cleavage and purification are mentioned above. 
The cleaved RNAs were dephosphorylated by alkaline phosphatase before 
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completely phosphorylated by T4 polynucleotide kinases (T4 PNK). Then 3’ 
adapter and 5’ adapter were ligated to the purified RNA sequentially by T4 
ssRNA Ligase (NEB), followed by further purification. Finally, the purified 
RNA fragments with both 3' and 5' adapters were reverse transcribed using 
primer SBS3 and amplified by primers SBS5 and SBS3. The PCR products 
were cloned into pCR2.1-TOPO vector for small RNA library construction. 
After transformation, the colonies were screened and 114 positive clones were 
sent for sequencing. After trimming the adapter sequences, all identified 
sequences were compared with the original sequence to identify the cleavage 
site. The DNA and RNA oligonucleotides used for library construction are 
listed in Table 2-4. 
Table 2-4: DNA and RNA oligonucleotides used for library construction 
 
ID Sequence (5’-3’) 
3’adapter pCTGTAGGCACCATCAATdideoxyC  







CHAPTER 3 Results and Discussion 
In this chapter, we report the first crystal structures of AfCsx3 in free 
form, in complex with manganese ion and in complex with an ssRNA 
fragment at 2.95 Å, 3.0 Å and 2.9 Å, respectively. AfCsx3 protein harbors a 
ferredoxin-like fold and forms dimer both in the crystal and in solution. 
Associated with the structural observation, we conducted a series of in vitro 
assays, such EMSA and cleavage assays, to elucidate the biochemical 
functions and catalytic mechanisms of AfCsx3. The AfCsx3 homodimer 
contains a distant ssRNA binding groove and two-metal-ion binding sites, and 
displays robust 3’-deadenylase activity in the presence of manganese ions.  
3.1 Sequence Analysis of AfCsx3 
So far, in total 47 proteins, including AfCsx3, are classified as the 
Csx3_III-U homologous protein. According to the distribution analysis, Csx3 
proteins show high preference to bacterial species (42/47). The length of the 
Csx3 proteins ranges from 89 to 384 amino acids, with the variation mainly in 
C-terminal sequences. Csx3 proteins occasionally fuse with Csx1 at the 
C-terminus as a small domain. With respect to the amino acid sequences, the 
identity of AfCsx3 to its top 14 homologues is around 50% which shows 
significant diversity in Csx3 superfamily (Figure 3-1).  
The secondary structural elements and expansions are shown beyond the 
alignments. As can be seen, analysis of the Csx3 sequences revealed a 
conserved domain ranging from residues ~40-80. This distinct domain, 
including one α-helices (α2) and three β-strands (β3, β4 and β5), is only found 
in Csx3 homologous proteins. It has been proved in this thesis that several 
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critical residues mainly locate in this domain, indicating the functional role 
may be conserved among the Csx3 family proteins (Figure 3-1). 
 
Figure 3-1 Sequence alignment of AfCsx3 with various Csx3 proteins 
from different organisms.  
The secondary structure elements are shown above the sequence. The 
α-helices are colored in orange, while the β-strands are colored in green. 
Conserved residues are shaded in yellow (100% identity), blue (>=75% 
identity) and green (>=50% identity), respectively. Asterisks indicate the 
critical residues involved in RNA recognition and catalysis. Conserved motif 
is underlined in red.  
Phylogenetic tree was constructed using amino acid sequences of AfCsx3 
and its top 14 homologues (Figure 3-2). AfCsx3 showed relatively close 
genetic relationship with Csx3 in Thermosediminibacter oceani, Dictyoglomus 
thermophilum and Dictyoglomus turgidum. Interestingly, all three strains are 
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bacterial species and the Csx3 proteins are adjacent to Type III-A system. In 
the two relatively close archaeal species Thermococcus sp. CL1 and 
Pyrococcus yayanosii, Csx3 proteins are found to locate within subtype Type 
III-A and III-B, respectively. Although no Csx3 has been characterized 
previously, the frequent co-occurrence suggests possible functional relation 
between Csx3 protein and the Type III systems. Associated with the notion 
that both Type III-A and III-B can target RNA for interference, Csx3 protein, 
probably in conjugation with other ribonucleases, might facilitate and/or 
accelerate the degradation of crRNA-targeted RNA in Type III CRISPR/Cas 
systems. 
 
Figure 3-2 Phylogenetic analysis of Csx3 Proteins. 
The amino acid sequences of 15 Csx3 proteins were aligned and phylogenetic 
tree was constructed using DNAMAN. The percentage of amino acid 
substitution is indicated. The branches of the tree are indicated by the genus 
and species names. 
3.2 Protein Purification, Crystallization and Optimization 
To study the function of AfCsx3, we expressed the recombinant protein in 
E. coli expression system. The protein is expressive and highly soluble, which 
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makes the purification step much easier. The pure AfCsx3 protein was 
obtained through a repeated purification strategy using Ni-NTA column. 
Limited by the current knowledge of AfCsx3, our first aim is to determine the 
crystal structure. Since AfCsx3 protein was destabilized and easily precipitated 
at higher protein concentration, we optimized the buffer condition with the 
addition of 500 mM imidazole which maintains the stability of AfCsx3 protein 
and prevents protein precipitation. Therefore, the protein was resolved in a 
buffer solution containing 20 mM Tris-HCl (pH 7.5), 125 mM NaCl, 5% (v/v) 
Glycerol and 500 mM imidazole and then concentrated to ~15 mg/ml for 
subsequent crystallization (Figure 3-3A).  
 
Figure 3-3 Protein purification, crystallization and optimization. 
(A) Purified native (upper panel) and selenium-substituted (lower panel) 
AfCsx3 proteins resolved on 15% SDS-PAGE. The protein ladders are 
indicated with estimated molecular weight. 
(B) Crystals and diffraction patterns of AfCsx3-RNA (upper panel) and 
AfCsx3/AfCsx3-manganese ion (lower panel), respectively. 
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Table 3-1: Data collection and refinement statistics 
 AfCsx3 AfCsx3-Mn AfCsx3-ssRNA 
Space group P3221 P3221 I212121 
PDBID 3WZG 3WZH 3WZI 
Wavelength (Å) 0.9792 1.5418 1.075 
Cell dimensions     
a  (Å) 87.27 86.73 71.17 
b  (Å) 87.27 86.73 80.29 
c  (Å) 112.69 112.53 181.23 
Α, β, ɣ(˚) 90, 90, 120 90, 90, 120 90, 90, 90 
Molecules/ASU 2 2 2 
Resolution (Å) a 2.95 (3.0-2.95) 3.3 (3.36-3.3) 2.9 (2.95-2.9) 
Rsym (%) a 8.7 (52.3) 13.3 (52.4) 8.8 (34.8) 
I/σ(I) 24.7 (3.9) 20.0 (4.8) 48.5 (7.5) 
Completeness (%) a 100 (99.9) 99.6 (100) 99.1 (89.4) 
Redundancy a 5.7 (5.8) 10.9 (10.7) 13.3 (10.6) 
FOM (50~2.95)  0.412 - - 
Resolution (Å)                                             
No. reflections 10,332 7,155 11,284 
Rwork (Rfree) (%) 18.6 (22.3) 22.1 (25.7) 20.7 (23.5) 
No. atoms    
Protein 1,553 1,545 1,696 
MN - 5 - 
RNA - - 44 
Water 22 25 10 
B-factors (Å2)    
Protein 58.71 37.98 76.39 
MN - 49.74 - 
RNA - - 115.2 
Water 42.67 14.07 62.03 
R.m.s. deviations    
Bond lengths (Å) 0.017 0.015 0.018 
Bond angles (º) 1.92 1.80 1.83 
% favored 
(disallowed)  
in Ramachandran plot 
91.3 (0.0) 83.7 (0.0) 90.7 (0.0) 
 
a Values for the highest-resolution shell are in parentheses. 
AfCsx3 protein samples are subjected to systematically crystallization 
screening with hundreds of conditions. With further optimization, the crystals 
are obtained for AfCsx3, manganese-soaked AfCsx3 and AfCsx3-RNA (Figure 
3-3B, left panel). The quality of the crystals was tested by the X-ray machine 
at home so that only crystals with good diffraction pattern were used for data 
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collection at Shanghai Synchrotron Radiation Facility (Figure 3-3B, right 
panel). The crystallographic statistics details of the structures are listed in 
Table 3-1. 
3.3 Overall Structure of AfCsx3 in Free Form 
The structure of AfCsx3 in free form was determined in space group 
P3221 using the single anomalous diffraction (SAD) method against a data set 
collected on a selenium-substituted AfCsx3 at a wavelength of 0.9792 Å, and 
refined to a resolution of 2.95 Å.  
 
Figure 3-4 Stereo view cartoon representation of AfCsx3.  
AfCsx3 structure reveals a ferredoxin-like fold with six β-stranded anti-parallel 
β-sheets located at one side and two α-helices resided at the other side. The 
numbered secondary structures are in the order of appearance in the amino acid 
sequence. The α-helices are shown in yellow while the β-strands and loop 
regions are shown in green.  
There are two AfCsx3 molecules per asymmetric unit and each molecule 
comprises residues of 1-96 aa. The disordered C-terminal region containing 
residues of 97-104 aa is omitted from the model (Figure 3-4). The overall fold 
of AfCsx3 molecule resembles a ferredoxin fold with two α-helices and six 
β-strands assembled in the order of β-β-α-β-α-β-β-β, which belongs to the α+β 
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protein fold class. The six β-strands form an anti-parallel β-sheet, which is 
located at one side, whereas the two α-helices reside at the other side (Figure 
3-4).  
 
Figure 3-5 Dimer formation of AfCsx3 in crystal and in solution. 
(A) AfCsx3 dimer is presented in a cartoon view and the two molecules are 
colored in yellow and magenta, respectively. AfCsx3 dimer is aligned by 2-fold 
non-crystallographic symmetry-related axis.  
(B) Analytical ultracentrifugation determines the approximate molecular mass 
of AfCsx3 dimer in solution. Sedimentation velocity (SV) experiments were 
conducted in buffer containing 100 mM NaCl, 25 mM Tris-HCl (pH 7.5), 4 
mM DTT and 100 mM imidazole. The sedimentation coefficient and f/f0 were 
obtained with c(s) method using the Sedfit software. 
In the crystal, two non-crystallographic symmetry-related AfCsx3 
molecules show a buried surface area of ~1,100 Å2/molecule (around 1/6 of 
the surface area of one molecule), suggesting that AfCsx3 also forms dimer in 
its physiological state (Figure 3-5A). Consistent with structural observations, 
the apparent molecular mass of AfCsx3 was determined as ~33.6 kDa in 
solution, through analytical ultracentrifugation (AUC) experiments (Figure 





Figure 3-6 Critical residues for dimer formation. 
The conserved aromatic residues (W50, H52 and H57) and hydrophobic 
residues (I49, A56, V67, L72 and V75) might be involved in dimerization. 
These residues are indicated and colored in cyan. SS-bridge formed by C53 is 
indicated in green dash line. 
Noticeably, the AfCsx3 dimer is formed by a disulfide bond contributed 
from C53 located at α2 from each molecule (Figure 3-6). Although the residue 
C53 is not a well conserved amino acid among Csx sequences, the residue C53 
resides within a highly conserved GRGPIWLY (C/A/G) F/YLV/IH motif 
(Figure 3-1, highlighted in red line underneath). This highly conserved motif 
forms a well-folded α-helix, which allows the formation of tight dimer via 
π-stacking and hydrophobic interactions through the conserved aromatic 
residues, such as W50, H52 and H57 (Figure 3-6). Strikingly, the interactions 
between these two monomers were substantially tight that the 
W50A/H52A/C53A/H57A quadruple mutant still formed dimer in solution 
according to the analytical gel filtration results (Figure 3-7). In addition to all 
the residues mentioned above, partially conserved hydrophilic and 
hydrophobic residues surrounding this well-conserved α-helix, such as 
residues E25, K28, D69, R84, E85, D87 and L27, I49, A56, V67, L72, V75, 
V77 are also involved in dimer stabilization through the contribution of 
hydrogen bonds and hydrophobic interactions, respectively. In particular, the 
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residues I49, W50, A56, and V75 form the hydrophobic core along the 
dimeric interface (Figure 3-6).  
 
Figure 3-7 Analytical gel filtration analysis of AfCsx3 dimerization.  
Wild-type and mutant AfCsx3 proteins were analyzed on SuperdexTM 200 
(10/300 GL) column. Analytical gel filtration was performed in buffer 
containing 100 mM NaCl, 25 mM Tris-HCl (pH 7.5), 4 mM DTT and 100 
mM imidazole. The alignment of corresponding curves was made by 
OriginPro 9.1. 
To investigate the function of AfCsx3 and reveal its putative mode of 
action in CRISPR/Cas-mediated host defense, a homologue search was 
performed using the refined AfCsx3 structure against the Protein Data Bank by 
Dali server (Holm and Rosenstrom 2010). However, no close structural 
homologues were found and the closest match was an antisigma-factor 
antagonist (PDBID: 3OIZ) with a Z score of 5.2.  
 71 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
 
Figure 3-8 Structure comparison of AfCsx3 with PfCas6, TtCas6e and 
PaCas6f.  
Structures of Cas6 from Pyrococcus furiosus (PDBID: 3I4H), Cas6e from 
Thermus thermophilus (PDBID: 1WJ9) and Cas6f from Pseudomonas 
aeruginosa (PDBID: 2XLK). The ferredoxin-like domains of the structures are 
colored in yellow and magenta, respectively. PaCas6f is an exception with 
only one ferredoxin-like domain. 
On the other hand, the dimeric ferredoxin-like fold revealed by the 
AfCsx3 dimer structure prompted us to speculate that the Csx3 protein may 
display RNA binding and cleavage activities, similar to other Cas proteins 
harboring one or two tandem ferredoxin domains, such as Cas6 (Carte, Wang 
et al. 2008), Cas6e (Sashital, Jinek et al. 2011) and Cas6f (Haurwitz, Jinek et 
al. 2010) (Figure 3-8). Consistent with the notion that AfCsx3 may act on 
RNA substrate, the electrostatic potential map of the AfCsx3 dimer showed a 
patch of protruding basic residues, including K20, K23, R46 and R71, lining 
along the dimer interface to form a shallow groove with the dimension of 8 Å 
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× 20 Å × 8 Å (width × length × depth), suggesting possible binding ability to 
nucleic acid (Figure 3-9). 
 
Figure 3-9 Superimposition of cartoon and electrostatic potential surface 
view of AfCsx3 dimer.  
The dimeric interface harbors a continuously positive-charged groove 
composed of four residues from each molecule. The positive-charged residues 
are shown as sticks and colored in red. 
3.4 AfCsx3 is a Manganese-Dependent Ribonuclease 
To validate the nucleic-acid binding ability of AfCsx3, EMSA were 
performed with AfCsx3 and the 37 nt repeat ssRNA derived from A. fulgidus 
CRISPR sequence. As is shown, the retarded bands were generated with the 
addition of AfCsx3 protein (Figure 3-10A). The subsequent coomassie blue 
staining confirmed that the retarded bands were caused by the formation of 
protein-RNA complex. Therefore, we demonstrated that AfCsx3 displayed 




Figure 3-10 AfCsx3 shows binding and cleavage ability to Af repeat 
ssRNA. 
(A) EMSA experiment was conducted by using increasing amount of protein 
and 10 mM repeat ssRNA. RNA and protein were visualized by SYBR Gold 
(left panel) and subsequent coomassie blue (right panel) staining, respectively. 
Unbound- and bound-ssRNA RNA substrates are indicated. Arrow indicates 
Af repeat ssRNA with possible secondary structure.  
(B) Ribonuclease activity displayed by AfCsx3 on repeat ssRNA in the 
presence of MgCl2, CaCl2 and MnCl2 at 25°C, 35°C and 55°C, respectively. 
Reaction with no protein added serves as control. The RNA substrates and 
products are indicated. 
To investigate whether AfCsx3 is a ribonuclease similar to other known 
Cas6 proteins comprising ferredoxin-like domains, we further performed 
AfCsx3-mediated cleavage assays by using the Af repeat ssRNA as substrate. 
Taking into consideration that the optimal culture condition of A. fulgidus is 
83 °C and that many ribonucleases from archaeal strains employ different 
divalent cations for substrate cleavage, we optimized the reaction conditions 
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of cleavage assays by testing the combination of three temperature (25 °C, 
35 °C and 55 °C) and three divalent cations (Mg2+, Ca2+ and Mn2+). Notably, 
the repeat ssRNA was cleaved in the presence of manganese ions, but not in 
the presence of magnesium or calcium ions at 25°C, 35°C or 55°C (Figure 
3-10B). Therefore, we demonstrated that AfCsx3 displayed ribonuclease 
activity towards Af repeat ssRNA. 
 
Figure 3-11 AfCsx3 is a sequence-specific ribonuclease. 
(A) Binding of AfCsx3 with different nucleic acids. EMSA experiment 
demonstrates that AfCsx3 shows no binding abilities with the Af repeat ssDNA 
or an unrelated ssRNA. Unbound- and bound-nucleic acids are indicated. 
(B) Ribonuclease activity of AfCsx3 on different nucleic acid substrates. The 
asterisk indicates the product of cleavable repeat ssRNA. 
To validate the nucleic-acid binding preference of AfCsx3, EMSA was 
performed with AfCsx3 and several types of nucleic acids with different 
sequences. In contrast to the binding of Af repeat ssRNA, AfCsx3 displayed no 
observable binding abilities with the repeat ssDNA derived from A. fulgidus 
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CRISPR sequence or with an ssRNA with unrelated sequence (Figure 3-11A). 
The EMSA results demonstrate that AfCsx3 can distinguish the repeat ssRNA 
from repeat ssDNA and unrelated ssRNA, suggesting that AfCsx3 is a 
sequence-specific RNA binding protein. Consistent with the observation in 
EMSA experiment, AfCsx3 also failed to cleave repeat ssDNA or unrelated 
ssRNA under any given condition, indicating that AfCsx3 is a 
substrate-specific ribonuclease (Figure 3-11B). 
 
Figure 3-12 Mn-dependent ribonuclease activity of AfCsx3. 
(A) AfCsx3 shows manganese–dependent ribonuclease activity. The 
manganese-dependent ribonuclease activity is either eliminated by the addition 
of EDTA or interfered by addition of excessive quantities of Mg2+ or Ca2+ in 
the reactions. Reaction with no addition of metal ions serves as control. 
(B) AfCsx3 displayed ribonuclease activity on repeat ssRNA in the presence of 
different divalent cations. 
To explore the importance of manganese ions in AfCsx3-mediated 
ssRNA catalysis, we performed the cleavage assays under several optimized 
conditions. As is shown, the addition of EDTA to chelate manganese ions 
dramatically reduced the cleavage activity of AfCsx3 (Figure 3-12A). 
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Additionally, although the addition of excess calcium (40 mM or 100 mM) or 
magnesium ions (40 mM or 100 mM) had negative impact on 
AfCsx3-mediated ssRNA cleavage, AfCsx3 still showed obvious ribonuclease 
activity, presumably due to the high binding affinity between AfCsx3 and 
manganese ions (Figure 3-12A). Thus, these results demonstrated that AfCsx3 
is a manganese-dependent ribonuclease, in contrast to Cas6 homologues that 
function in an ion-independent manner (Carte, Wang et al. 2008, Wang, 
Preamplume et al. 2011).  
Moreover, more divalent metal ions were tested. Interestingly, the repeat 
ssRNA was partially cleaved in the presence of cobalt ions, in contrast to other 
divalent cations, such as nickel, barium and strontium ions (Figure 3-12B). 
Notably, although magnesium, calcium, manganese and cobalt ions have the 
coordination number of six, the radius of the cobalt ion is closest to that of the 
manganese ion. We speculate that cobalt ion may mimic the structural and 
functional role of the manganese ion during AfCsx3-mediated catalysis. Hence, 
having the right coordination property and suitable size of the divalent ion is 
important for AfCsx3-mediated ssRNA cleavage.  
3.5 Enzymatic Kinetic Analysis of AfCsx3 
Furthermore, to understand the basic enzymatic mechanism, we tried to 
determine the factors which may affect the cleavage rate of AfCsx3 protein. 
There are several factors affecting enzyme activity, such as temperature, pH 
value and the concentration of enzyme, substrate or metal ions. Here, we 
conducted cleavage assays with the variation of temperature, pH value and the 




Figure 3-13 Effect of temperature on ribonuclease activity of AfCsx3. 
(A) The cleavage reactions products under different temperatures were 
resolved on urea-denaturing PAGE. The gel was visualized and the intensity 
of substrates and products is quantified using Genesnap software. Reaction 
with no protein added serves as control.  
(B) The temperature profiles were measured from 20 °C to 60 °C. The 
corresponding temperature-dependent statics curve was constructed using 
OriginPro 9.1. The cleavage rate is represented by the percentage of cleaved 
RNA product. 
Temperature is the most commonly tested factor in enzymatic reactions. 
Our cleavage assays and corresponding statics analysis showed that the 
cleavage rate of AfCsx3 protein was accelerated with the increasing of 
temperature from 20 °C to 50 °C (Figure 3-13). Afterwards, the cleavage rate 
is almost constant from 50 °C to 60 °C. In particular, AfCsx3 protein still 
showed robust cleavage activity even the reaction temperature was as high as 
80 °C (Figure 3-13A). Consistent with the notion that AfCsx3 protein is 
derived from the hyperthermophilic archaea A. fulgidus, AfCsx3 shows high 




Figure 3-14 Effect of ion concentration on ribonuclease activity of AfCsx3. 
(A) The cleavage reactions products under different ion concentrations were 
resolved on urea-denaturing PAGE.  
(B) The ion concentration profiles were measured in 0.001, 0.01, 0.1, 1, 5, 10 
and 20 mM of manganese ions. The corresponding ion 
concentration-dependent statics curve was constructed using OriginPro 9.1. 
In addition to temperature, we also tested the optimal ion concentration 
for AfCsx3-mediated ssRNA cleavage. According to the cleavage assays, the 
accumulation of RNA products was accelerated with the increasing of ion 
concentration (Figure 3-14A). The corresponding statics analysis showed that 
the cleavage rate of AfCsx3 increased significantly with the ion concentration 
ranged from 0.001 to 1 mM (Figure 3-14B). The maximal cleavage rate of 
AfCsx3 requires approximate 5 mM ions. Afterwards, the ion concentration is 




Figure 3-15 Effect of pH on ribonuclease activity of AfCsx3. 
(A) The cleavage reaction products under different pH values were resolved 
on urea-denaturing PAGE. The gel was visualized and the intensity of 
substrates and products is quantified using Genesnap software.  
(B) The pH profiles were measured in 20 mM of two different buffers: 
Sodium Cacodylate buffer (pH 5.0-7.0) and Tris-HCl buffer (pH 7.0-9.0). The 
corresponding pH-dependent statics curve was constructed using OriginPro 
9.1. 
Furthermore, pH values are also tested and the optimal pH range for 
AfCsx3-mediated ssRNA cleavage was verified. Since manganese ions rapidly 
precipitate in buffer with pH value more than 9.0, the cleavage assays were 
performed under two buffer conditions covering the pH range from 5.0 to 9.0 
(Figure 3-15A). The corresponding statics analysis showed that the cleavage 
rate of AfCsx3 protein was accelerated with the increasing of pH in 20 mM 
Sodium Cacodylate buffer (pH 5.0-7.0) (Figure 3-15B). The AfCsx3 protein 
exhibited the maximum nuclease activity at pH 7.0 under both buffer 
conditions. Afterwards, the cleavage rate is almost constant. These results 
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suggest that AfCsx3 protein favors basic environment for RNA cleavage 
(Figure 3-15B).  
3.6 Mechanisms of RNA Catalysis by AfCsx3  
Following the identification of the basic enzymatic mechanisms, we aim 
to further investigate the catalytic mechanisms of AfCsx3. Previously, we have 
demonstrated that AfCsx3 is a manganese-dependent ribonuclease. To 
investigate the structural role of manganese ions in the catalytic mechanisms, 
the structure of AfCsx3 in complex with the manganese ion was determined by 
soaking AfCsx3 crystals with 1 mM manganese (II) chloride solution. The 
manganese-soaked AfCsx3 crystals were screened and the diffraction data set 
was collected (Table 3-1).  
 
Figure 3-16 Structure of AfCsx3 bound to manganese ions. 
(A) Overall cartoon and ribbon view of AfCsx3 in complex with manganese 
ions. Critical residues involved in the coordination of manganese ions are 
indicated and colored by element. Manganese ions are indicated as spheres in 
red mesh contours and colored in wheat. 
(B) Cartoon view of the catalytic sites of AfCsx3. Five residues, H57, K58, 
H60, H80 and E85, are involved in the coordination of two manganese ions. 
Catalytic residues are shown as sticks and coloured by element. Manganese 
ions (Mn A and Mn B) are indicated and colored in wheat.  
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The crystal structure of AfCsx3 in complex with manganese ions was 
determined and refined at 3.0 Å. The Fo-Fc Fourier difference map showed 
two pairs of strong ball-shaped peaks along the dimer interface, which were 
assigned as manganese ions (Figure 3-16A). In the crystal, each pair of 
manganese ions is coordinated by critical residues contributed by two 
molecules. Manganese ion A is coordinated by 1-H57, 1-K58 and 2-E85 (the 
prefix number refers to the ordering of the molecule), whereas manganese ion 
B is coordinated by 1-H57, 1-H60, 2-H60 and 2-H80 (Figure 3-16B). 
 
Figure 3-17 Identification of catalytic residues.  
(A) AfCsx3 mutants were generated by alanine scanning mutagenesis on the 
key residues participating in the coordination of manganese ions. The protein 
ladders are indicated with estimated molecular weight. 
(B) Ribonuclease activity assays were performed using wild-type and mutant 
AfCsx3 proteins with Af repeat ssRNA. Reaction with no protein added serves 




To validate whether the residues involved in manganese coordination are 
the catalytic residues for ssRNA cleavage, alanine substitutions were 
introduced to these critical residues and ssRNA cleavage assays were 
performed. The protein mutants with single- or dual-point mutations were 
generated and purified by the same protocols used for wild-type AfCsx3 
purification (Figure 3-17A). 
According to the structure of protein-manganese complex, both 1-H60 
and 2-H60 residues are involved in manganese ion Mn B coordination, 
indicating residue H60 contributes two contact sites with Mn B (Figure 3-16B). 
Consistent with the structural observation, the alanine substitution of residue 
H60 abolished RNA cleavage activity, probably due to the failure in Mn B 
coordination (Figure 3-17B). Similarly, the structure showed that H57 residue 
also provides two contact sites for the coordination of both Mn A and Mn B 
(Figure 3-16B). As expected, the alanine substitution of residue H57 
significantly decreased RNA cleavage activity (Figure 3-17B). Likewise, 
consistent with the structural observation that residues E85 and H80 are 
involved in Mn A and Mn B coordination, respectively (Figure 3-16), the 
alanine substitution of either H80 or E85 also interfered the ssRNA cleavage 
activity (Figure 3-17B).  
Surprisingly, although lysine is a positive-charged residue, K58 is 
observed to be located near Mn A in the crystal structure suggesting that K58 
may also be involved in the coordination of manganese ions (Figure 3-16). 
Consistent with our structural observation, the structure of CRISPR-associated 
Cmr2 protein in complex with manganese ions showed that the side chain of 
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lysine residue directly coordinated with two manganese ions (Benda, Ebert et 
al. 2014). In addition to structural observations, a literature survey has also 
shown that lysine residues are proposed to coordinate many metal ions, such 
as Ca2+, Mg2+, Fe2+ and Mn2+ in previous studies (Dokmanic, Sikic et al. 2008). 
Although the single alanine substitution of residue K58 did not show any 
negative impact on ssRNA cleavage, the double alanine substitutions of 
H57/K58 and K58/E85 significantly decreased RNA cleavage activity (Figure 
3-17B). These results suggested that K58 should also contribute to the 
manganese ion coordination, yet not as significantly as the other residues. 
Therefore, we conclude that the active sites of AfCsx3 comprise two 
manganese ions and the surrounding residues, including H57, K58, H60, H80 
and E85.  
 
Figure 3-18 Conserved basic patches along the shallow groove. 
The electrostatic potential surface view of AfCsx3 dimer reveals several 
positive-charged residues lining along the dimer surface. These residues are 
potentially involved in the RNA recognition. The front (left panel) and back 




3.7 Mechanisms of RNA Recognition by AfCsx3 
To investigate whether the RNA recognition by AfCsx3 was contributed 
by the conserved basic patch lining along the shallow groove (Figure 3-18), a 
series of AfCsx3 mutants (R46A, R71A, R46A/R71A, K20A/K23A and 
K23A/R84A) were generated and purified by the same protocols used for 
wild-type AfCsx3 purification (Figure 3-19A).  
 
Figure 3-19 Identification of RNA binding residues. 
(A) AfCsx3 mutants were generated by alanine scanning mutagenesis of the 
positive-charged residues indicated by the electrostatic potential surface view 
of AfCsx3 dimer. The protein ladders are indicated with estimated molecular 
weight. 
(B) EMSA experiments were performed using wild-type and mutant AfCsx3 
proteins with Af repeat ssRNA. Arrow indicates Af repeat ssRNA with 
possible secondary structure. Unbound- and bound-nucleic acids are indicated. 
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EMSA experiments were performed by incubating wild-type or mutant 
AfCsx3 proteins with repeat ssRNA. As is shown, the alanine substitutions of 
residues K20/K23 or K23/R84 showed little impact on binding affinity 
compared with that of wild-type AfCsx3 protein (Figure 3-19B). In contrast to 
residues K20/K23 and K23/R84, the alanine substitutions of residues R46 or 
R71 significantly decreased the RNA binding ability. Associated with the 
structural observation, these data suggests that R46 and R71 are key residues 
contributing to the RNA recognition and that the shallow groove along the 
AfCsx3 dimer interface could be the ssRNA binding region (Figure 3-18). 
Meanwhile, the alanine substitutions of the catalytic residues did not affect 
ssRNA binding, excluding the possibility that the decrease of cleavage activity 
was caused by the interference of ssRNA binding (Figure 3-19B). Furthermore, 
analytical gel filtration showed that the introduction of mutations at all these 
critical residues did not affect AfCsx3 dimerization in solution (Figure 3-7). 
To investigate the ssRNA binding properties of AfCsx3, the structure of 
AfCsx3 in complex with an ssRNA fragment was determined by molecular 
replacement at space group I212121 at 3.0 Å (Table 3-1). The refined model 
comprises two AfCsx3 molecules with residues ranging from 1 to 104 aa and 
one 4 nt ssRNA fragment, which is located along the dimer interface (Figure 
3-20A). The observed ssRNA binding pocket has a cuboid-like shape with the 




Figure 3-20 Overall structure of AfCsx3 bound to repeat ssRNA 
fragment. 
(A) The cartoon representation of AfCsx3 in complex with ssRNA fragment.  
(B) Electrostatic potential surface view of AfCsx3 in complex with ssRNA 
fragment. The view is the same as that in (A). Electron densities for bound 
ssRNAs are shown in red mesh contours. The map was calculated using Fo-Fc 
coefficients and phases from the refined structure, but with the residues 
omitted from the Fc calculation. The map is contoured at 3σ. The ssRNA 
5’-N1-N2-N3-N4-3’ is shown in stick model. The key residues involved in 
AfCsx3-RNA interaction are indicated and colored in red (serving as walls) 
and cyan (serving as base), respectively. 
Although the 37 nt repeat ssRNA was incubated with AfCsx3 for 
co-crystallization, only the 4 nt ssRNA model was built in our complex. We 
found that the repeat ssRNA was degraded during the long-term crystallization 
incubation. Therefore, the extra electronic density could be assigned to any 
tetramer derived from repeat ssRNA. Nevertheless, to build an illustrative 
model showing the interactions between AfCsx3 and RNA, we assigned four 




Figure 3-21 A zoomed in view of Figure 3-20 showing the RNA binding 
pocket. 
(A) The cartoon and ribbon representation of detailed view of RNA binding 
region.  
(B) The electrostatic potential surface representation of detailed view of RNA 
binding region. The view is the same as that in (A). Electron densities for 
bound ssRNA are shown in red mesh contours. The map was calculated using 
Fo-Fc coefficients and phases from the refined structure, but with the RNA 
residues omitted from the Fc calculation. The map is contoured at 3σ. The 
ssRNA 5’-N1-N2-N3-N4-3’ is shown in stick model. The key residues involved 
in AfCsx3-RNA interaction are indicated and colored in red (serving as walls) 
and cyan (serving as base), respectively. 
The cuboid-like ssRNA binding pocket is formed by two parts. The side 
chains of the critical residues R46 and R71 serve as the walls lining along the 
bound ssRNA fragment. Meanwhile, the side chains of the conserved residues 
I49, H52 and P48, together with the main chain of residues G47 and R46, 
serve as the base holding the bound ssRNA fragment (Figure 3-21A). 
Particularly, the bound ssRNA fragment adopts an extended conformation 
with the phosphorus moieties clustering inside and the base moieties extending 
out and inserting into the preformed pockets within AfCsx3 (Figure 3-21B).  
The bases of N1 and N3 are buried inside the narrow pockets formed by 
residues P70, Y68, S44 and G45, whereas the bases of N2 and N4 are located 
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at the top of the peptide backbones of residues G47 and P48 (Figure 3-21). In 
addition, the bound ssRNAs, including the moieties of ribose, phosphorus 
backbone and base, are located at the top of a specific AfCsx3 structural motif 
(45GRGPI50) adopting a sharp “U-turn” shape linking the well-structured β3 
and α2 (Figures 3-1 and 3-21). Hence, the strong hydrophobic interactions 
between the “U-turn” structure and the ssRNA fragment, within 5 Å distance, 
stabilize ssRNA binding. Notably, residue R71 and the “45GRGPI50” structural 
motif are well conserved among Csx3 proteins, suggesting the unique ssRNA 
binding pocket within the AfCsx3 dimer should be conserved among Csx3 
proteins (Figures 3-1). 
3.8 AfCsx3 is a Deadenylation Exonuclease 
So far, we have characterized the in vitro biochemical functions of 
AfCsx3 ribonuclease, including the mechanisms of RNA recognition and 
catalysis. We further aim to decipher the biological role of AfCsx3. To 
investigate the molecular mechanism of AfCsx3-mediated ssRNA cleavage, 
cleavage assays were performed by AfCsx3 in parallel with AfCas6, a 
homologue to Cas6 in P. furiosus (Carte, Wang et al. 2008). Notably, both 
AfCsx3 and AfCas6 were able to cleave the repeat ssRNA, yet the cleavage 
sites recognized by AfCsx3 and AfCas6 are apparently different (Figure 
3-22A).  
Additionally, the cleavage product produced by AfCsx3 is cleavable by 
AfCas6, whereas the cleavage product produced by AfCas6 is resistant to 
AfCsx3 cleavage (Figure 3-22A). Since Cas6 specifically cleaves within the 
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repeat ssRNA at 8 nt upstream of 3’ terminus (Figure 3-22B), we speculate 
that AfCsx3 may recognize the sequence at 3’-terminus of the repeat ssRNA. 
 
Figure 3-22 Subsequent-cleavage assays using AfCsx3 and AfCas6. 
(A) Subsequent-cleavage assay showing different target sites in repeat ssRNA 
by AfCsx3 and AfCas6. Solo cleavage by AfCsx3 or AfCas6 and reaction with 
no protein added serve as controls. The RNA substrates and products cleaved 
by AfCsx3 and AfCas6 are indicated.  
(B) The secondary structure of repeat ssRNA was predicted by using the 
M-fold web server (http://mfold.rna.albany.edu/?q=mfold). Red arrows under 
and above the sequence indicate the cleavage sites of repeat ssRNA by AfCas6 
and AfCsx3, respectively.  
To identify the cleavage sites of the repeat ssRNA catalyzed by AfCsx3, 
we constructed a small RNA library by cloning the cleaved RNA fragments 
into PCR TOPO-2.1 vector for sequencing. The RNA products derived by 
AfCsx3 catalysis showed four consecutive bands by decreasing the incubation 
time and fine-tuning the protein/ion concentration when the cleavage assays 
were performed (Figure 3-23A). To avoid any false positive hits during the 
following selection and sequencing process, we excised the two product bands 




Figure 3-23 Identification of the RNA cleavage sites catalyzed by AfCsx3. 
(A) Urea-denaturing PAGE showed four bands corresponding to the ssRNA 
substrate and three dominant cleavage products (arrows on the gel). The two 
lower bands are excised for RNA extraction and subsequent library 
construction. 
(B) Statistical analysis of small RNA library derived from cleaved repeat 
ssRNA by AfCsx3. Two dominant bars represent the two cleaved products for 
library construction. 
Remarkably, the sequencing results showed that 75% of repeat ssRNA 
was cleaved between 35th nt and 36th nt, whereas 21% of repeat ssRNA was 
cleaved between 34th nt and 35th nt by AfCsx3 (Figure 3-23B). In associated 
with the cleavage results in Figure 3-23A, all three cleavage sites were located 
adjunct to adenines at the 3’ ending sequence of the repeat ssRNA, which 
suggests that AfCsx3 may specifically target ssRNA substrates with the “AA” 
stretch at 3’ terminus (Figure 3-22B).  
To validate our speculation, more ssRNAs were tested for cleavage by 
AfCsx3. Three tested repeat ssRNAs are derived from the CRISPR sequences 
of C. thermocellum, P. furiosus and T. fusca, respectively (Table 1-3) 
(Rousseau, Gonnet et al. 2009). Notably, two ssRNAs were cleavable by 




Figure 3-24 Ribonuclease activity of AfCsx3 on different RNA substrates.  
Repeat ssRNAs are derived from CRISPR sequence of Clostridium 
thermocellum (Ct), Pyrococcus furiosus (Pf) and Thermobifida fusca (Tf), 
respectively. The asterisks indicate the products of cleavable repeat ssRNAs.  
Surprisingly, all the cleavable ssRNAs tested so far contain “(A)AAG/C” 
sequences at 3’-terminus. By contrast, the two non-cleavable ssRNAs end with 
5’-GACCG-3’ and 5’-CAUUU-3’, respectively, which lack the “AA” stretch 
(Table 1-3). These results suggest that the “AA” stretch located near the 3' 
terminus might be targeted by AfCsx3. In general, AfCsx3 is able to cleave the 
ssRNA with the “AA” stretch at 3’ terminus and produce three consecutive 
dominant cleavage products derived from A. fulgidus repeat ssRNA ending 
with the 5’-GAAAG-3’ sequence. These results prompted us to speculate that 
AfCsx3 may function as a deadenylation exonuclease specifically targeting the 
poly (A) tail of the RNA in nature.  
To further confirm that AfCsx3 displays deadenylase activity, we 
performed the RNA cleavage assay by using an in vitro transcribed ssRNA 
containing a 3’- 7 nt oligo (A) tail as the substrate. Strikingly, time-course 
deadenylation assay showed that the ssRNA fragments derived from AfCsx3 





Figure 3-25 AfCsx3 demonstrates deadenylation exonuclease activity. 
(A) Time-course deadenylation assays towards an in vitro transcribed RNA 
substrate ending with 3’-oligo (A) tail. A7 and A10 indicate the intact RNA 
substrates containing seven and ten 3’ adenylate residues and A0 indicates the 
fully deadenylated RNA product. The cleavage sites are indicated with arrows 
above the sequence. Reaction with no protein added serves as control. 
(B) Deadenylation assays towards an in vitro transcribed RNA substrate 
ending with 10 nt 3’-oligo (A) tail. The ladder is shown with a size range from 
4~14 nt. 
Similarly, in vitro transcribed ssRNA with a 3’- 10 nt oligo (A) tail was 
also cleaved into eleven consecutive RNA bands (Figure 3-25A, right panel). 
These results strongly suggest that AfCsx3 is a deadenylation exonuclease 
specifically targeting ssRNA substrates with poly (A) tails. Consistent with 
this hypothesis, the two ssRNAs tested above also contain internally 
embedded oligo (A) stretches, which are not recognizable by AfCsx3, 
demonstrating that the internal oligo (A) sequence is a poor substrate for 
AfCsx3-mediated cleavage. Furthermore, to test the maximal length of the 
poly (A) stretch that can be removed, we generated an in vitro transcribed 
RNA substrate Oligo A (14 nt) with ten consecutive adenines at 3' terminus. 
As expected, the Oligo A substrate was fully deadenylated to produce a 4 nt 




Figure 3-26 AfCsx3 deadenylase activity on RNA substrates with various 
3’ terminal nucleotides.  
(A) Ribonuclease activity of AfCsx3 on in vitro transcribed ssRNA substrates 
ending with various types of terminal nucleotides at 3’-oligo (A) tail.  
(B) Ribonuclease activity of AfCsx3 on ssRNA substrates with various types 
of terminal 3’-oligo tails. 
Moreover, in order to identify whether the 3’-terminal nucleotide other 
than A could be tolerated, RNA oligos with an additional G/C/U were 
generated by in vitro transcription and subjected to cleavage assay. The results 
showed that all three RNA oligos were cleavable by AfCsx3, yet the cleavage 
rates were decreased compared to the RNA oligo substrate with homogenous 
oligo (A) tail (Figure 3-26A). In addition, AfCsx3 showed no cleavage activity 
against oligos with G, C or U stretches at the 3’-terminus (Figure 3-26B). 




The robust deadenylation exonuclease activity displayed by AfCsx3 
prompted us to investigate the putative deadenylation mechanism of AfCsx3. 
In the AfCsx3 structure, the observation of two pairs of well-refined 
manganese ions coordinated by H57, K58, H60, H80 and E85 within each 
catalytic core prompted us to speculate that AfCsx3 may adopt the 
two-metal-ion-dependent catalysis mechanism for RNA deadenylation. 
Similar to AfCsx3, the Pop2p deadenylase from Schizosaccharomyces pombe 
has also been demonstrated to adopt the two-metal-ion-dependent catalysis 
mechanism (Jonstrup, Andersen et al. 2007). The crystal structure of AfCsx3 
in complex with manganese ions was compared with the crystal structure of 
SpPop2p in complex with magnesium ion (Figure 3-27). In despite of the 
structural differences, the active sites of both AfCsx3 and SpPop2p are 
composed of several key residues and two metal ions. 
 
Figure 3-27 Structural comparison of the active sites of AfCsx3 and 
SpPop2p.  
The structures of AfCsx3 and SpPop2p (PDBID: 2P51) are shown in cartoon 
mode and the key residues are indicated and colored in green. Manganese and 
magnesium ions are indicated and colored in wheat.  
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However, Csx3 family proteins possess great variation in the number and 
sequence of amino acids. Sequence alignment showed that only the central 
Csx3_III-U homologous domain, approximately containing the residues of 
AfCsx3 40GVVI---VVQS80, was relatively conserved. No classical 
DEDDH-like motifs, typical for deadenylation exonuclease, were observed 
among the aligned Csx3 proteins (Figure 3-1). Hence, the modelling and 
mutation efforts strongly suggest that AfCsx3 could be a de novo mRNA 
deadenylation exonuclease employing a two-metal-ion mechanism.  
3.9 Discussion 
Our results have shown that AfCsx3 forms a homodimer comprising 
tandem ferredoxin domains and functions as a manganese-dependent 
deadenylation exonuclease. Surprisingly, our biochemical and structural data 
indicate that the recognition and cleavage of ssRNA by AfCsx3 occurs at 
physically distant sites, which are located at opposite surfaces. The crystal 
structure of AfCsx3 in complex with an ssRNA fragment shows that ssRNA 
binding sites are located at the shallow cuboid lining of residues R46 and R71, 
which is opposite to the active sites revealed by the crystal structure of AfCsx3 
in complex with manganese ions (Figure 3-28A). Moreover, structure-based 
mutagenesis analysis further confirmed that residues H57, K58, H60, H80 and 
E85 comprise the catalytic active sites, since the alanine substitution of either 




Figure 3-28 Superimposition of AfCsx3 structures. 
(A) Structural superimposition of AfCsx3 bound to ssRNA fragment (green) 
and AfCsx3 bound to manganese (cyan). The key residues involved in 
interaction with ssRNA and in coordination of manganese are indicated and 
colored in yellow and magenta, respectively. Manganese ions and ssRNA 
fragment are colored in red. 
(B) Electrostatic potential surface views of the structural superimposition. The 
views are the same as those in (a). The surface views show the separated RNA 
binding site and manganese ions binding site. The positive-charged residues 
which may contribute to the hypothetical path are indicated. 
Notably, superimposition of the structures of AfCsx3 in free form and in 
complex with ssRNA did not show structural rearrangement after ssRNA 
binding (r.m.s.d. 1.1Å, 97Cα), demonstrating that the ssRNA binding cuboid 
is pre-formed. Such observation indicates that the ssRNA binding sites and the 
catalytic sites should be constantly separated before and after ssRNA binding. 
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The physical separation of active sites from ssRNA binding sites observed in 
our AfCsx3 structures prompts us to speculate that there should be a path 
leading from the ssRNA recognition face of AfCsx3 to the catalytic active sites 
at the other face of AfCsx3. Consistently, it is observed that patches of positive 
electrostatic potential regions (K20, K23 and R84) are lined between the 
active sites and the binding sites (Figure 3-28B). In the crystal structure, the 
half-perimeter of AfCsx3, connecting the binding and active sites, is around 45 
Å, suggesting a minimal linker length of around 10 nucleotides is required to 
bridge the binding and cleavage sites. However, AfCsx3 was capable of 
cleaving RNA substrate and generated a final product with the length of 4 nt 
(Figure 3-25B), indicating that AfCsx3 protein moved along the RNA 
substrate while catalyzing consecutive deadenylation reactions. 
 
Figure 3-29 Alternative-syringe model of RNA recognition and cleavage 
by AfCsx3.  
The RNA substrate is colored in red. Incoming RNA substrate is recognized 
by AfCsx3 with the 5’-terminus bound to binding sites (B sites) while the 




Hence, we suggest that the AfCsx3 dimer provides two separate sites at 
opposite faces for RNA binding and cleavage, respectively. AfCsx3 binds to 
the incoming RNA near its 5’-terminus by binding sites on one surface and 
binds to the 3’-poly (A) tail by active sites on the opposite surface (Figure 
3-29). Thus, the RNA target can anchor its 5’-terminus at binding sites of 
AfCsx3, wrap around AfCsx3 and tether the downstream cleavage sites to 
AfCsx3 active sites on the opposite surface (Figure 3-29). The 2-fold-axis 
dimerization arrangement of AfCsx3 can provide an alternating-syringe model 
to bind, tether and cleave the incoming RNA using two different surfaces of 
AfCsx3 by turns (Figure 3-29). Therefore, our results strongly suggest that 
AfCsx3 is a deadenylation exonuclease employing a two-metal-ion catalytic 
mechanism.  
Notably, the AfCsx3-encoded gene is located within a cluster of cmr 
genes in the genome, which suggests that the deadenylase activity of AfCsx3 
may be associated with CMR-mediated RNA cleavage. RNA polyadenylation 
is a general post-transcriptional modification occurring in almost all organisms. 
In addition to functioning as the stabilizing element in eukaryotes, 
polyadenylation is also involved in the RNA degradation process throughout 
all life domains (Wyers, Rougemaille et al. 2005, Portnoy and Schuster 2006, 
Portnoy and Schuster 2006, Lange, Sement et al. 2009, Slomovic, Fremder et 
al. 2010). During the decay process, RNA is sequentially cleaved by 
endonuclease, added with poly (A) or poly (A)-rich tail, and degraded by 
hydrolytic exoribonucleases. In archaea, exosome-like complexes are known 
to accomplish the process of RNA polyadenylation and exonucleolytic 
degradation (Portnoy, Evguenieva-Hackenberg et al. 2005, Makino, Halbach 
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et al. 2013). Since CMR-mediated RNA cleavage only occurs in the region 
complementary to crRNA, little is known about the RNA degradation 
mechanisms after being cleaved by the CMR complex (Hale, Zhao et al. 2009, 
Benda, Ebert et al. 2014). We speculate that the Type III-B CRISPR/Cas 
defense process might be accomplished by CMR-mediated RNA cleavage and 
polyadenylation-stimulated RNA degradation by exosome-like complexes. 
AfCsx3 could be employed by A. fulgidus to cooperate with an exosome-like 
complex to facilitate the degradation of RNA products cleaved by CMR 
machinery. However, the role of AfCsx3 in the defense process is yet to be 
determined and more data are required to further investigate the function of 
AfCsx3 in vivo. Nevertheless, our current work has demonstrated the 
deadenylase activity of AfCsx3 and should provide important insights 




CHAPTER 4 Conclusion and Future Work 
Csx3 family proteins are mostly found in archaea and bacteria and are 
considered as putative CRISPR/Cas proteins. However, the exact function of 
Csx3 is largely unknown. In this study, we have determined the crystal 
structures of AfCsx3 in free form, in complex with manganese ions and in 
complex with an ssRNA fragment. In the AfCsx3 crystal, there are two 
molecules per asymmetric unit, which are symmetric-related in 2-fold axis. 
Considering its low molecular weight, the barrier surface area of 1101.7 Å per 
molecular indicates strong interaction between two molecules. In addition, the 
homodimer formation in solution has been verified by analytical 
ultra-centrifugation. These results suggest that dimerization of AfCsx3 may be 
essential for its biochemical activities. In addition, there are in total two 
α-helices and six β-strands in an order of β-β-α-β-α-β-β-β. Its terminal 
β-strands flip over to the center, forming a six-stranded, antiparallel β-sheet on 
one side while the other side is covered by two α-helices. The first crystal 
structure of Csx3 presented here should shed light on other crystal structures 
of the Csx3 superfamily in future. 
This study also characterized the biochemical functions of AfCsx3 based 
on the observation of its crystal structure. The atomic three-dimensional 
structure has revealed how AfCsx3 may recognize repeat ssRNA. According to 
the electrostatic potential map of AfCsx3 dimer, four positive residues of each 
molecular constitute a groove with possible nucleotide binding ability. The 
RNA binding ability has been proved by the EMSA experiments which have 
shown that AfCsx3 is able to specifically bind with repeat ssRNA. Meanwhile, 
AfCsx3 demonstrated no observable binding ability with forward or reverse 
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repeat ssDNA, dsDNA or unrelated RNA under our experimental condition. 
Furthermore, the results of mutagenesis and EMSA have shown that the 
RNA-binding ability of two single-point mutants, R46A and R71A, was 
significantly reduced while the other single-point mutants still maintained the 
binding ability. It is probably because R46 and R71, which are core residues, 
dominate the binding ability, and inactivation of single residue leads to the 
loss of binding ability. Consistent with our EMSA results, the structure of 
AfCsx3 in complex with an RNA fragment also demonstrates that RNA 
binding sites are located at the shallow cuboid lining of residues R46 and R71. 
Nevertheless, EMSA results cannot distinguish whether other tested residues 
are additional binding residues with weak binding affinity or that they are not 
involved in RNA recognition. EMSA is commonly used to detect the 
qualitative interaction for protein and nucleic acid other than quantitative 
purposes. As a quantitative assay, Isothermal Titration Calorimetry (ITC) is 
required to determine the binding affinity of single-point mutants and verify 
other binding residues in future studies. 
In addition, it was found that AfCsx3 shows robust ribonuclease activity 
with repeat RNA as substrate. Moreover, manganese ions were proved to be 
necessary for RNA cleavage. The results indicate that the ribonuclease activity 
of AfCsx3 is manganese-dependent in this study. The coordination of 
manganese ion in crystal structure was determined according to the structure 
of AfCsx3 in complex with manganese ions. Afterwards, five catalytic residues, 
H57A, K58A, H60, H80 and E85A were confirmed by mutagenesis and 
cleavage assay. The catalytic site is composed of residues H57, H60 and K58 
from one molecule and H60, H80 and E85 from the other. It is worth noting 
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that residues H57 and H60 make major contribution to the coordination of 
manganese ions according to the observation in the crystal structure. This is 
further evidenced by the notion that single-point mutation on residue H57 or 
H60 could abolish or significantly decreased the cleavage activity, while 
single-point mutations on the other three residues have relative less impact on 
cleavage activity. In addition, the abolishment of cleavage activity by alanine 
substitution of H60 is possibly caused by the failure in coordinating 
manganese ion B. Similarly, the dual-point mutation on residue H57 and E85 
also could abolish the cleavage activity, probably due to the failure in 
coordinating manganese ion A. These results indicate that at least two catalytic 
manganese ions are required for RNA cleavage. Based on all the results we 
obtained above, we further elucidated the biological function of AfCsx3 as a 
de novo deadenylation exonuclease. On the whole, this study has presented a 
comprehensive and detailed acknowledgement of RNA recognition and 
catalytic mechanism of AfCsx3 in vitro.  
The presented work provides important insights into the structural-related 
functions of the AfCsx3 as the foundation for future studies of the Csx3 
superfamily. From this project, we should have an idea of the RNA 
recognition and catalytic mechanism of AfCsx3. All the information should 
also be useful for further investigation of the biological role of AfCsx3 in the 
immune system. As for biochemical investigations in vitro, current research is 
mainly focused on isolated protein and limited to the structural aspects. 
However, the role of its deadenylase activity is still unknown and further 
investigation of the functional studies of AfCsx3 in vivo would be required. 
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Table S-1: Plasmids constructs in this thesis 
Plasmids Description 
Wild-type  For crystallization, EMSA, nuclease assays,  
AUC and analytical gel filtration 
I49M/L51M For crystallization 
H57A For nuclease assays 
K58A For nuclease assays 
K85A For nuclease assays 
H57A/K58A For nuclease assays 
H57A/K85A For nuclease assays 
K58A/K85A For nuclease assays 
H60A For nuclease assays 
H80A For nuclease assays 
R46A For EMSA 
R71A For EMSA 
K20A/K23A For EMSA 
K23A/R84A For EMSA 
R46A/R71A For EMSA and analytical gel filtration 
H57A/K58A/K85A For EMSA and analytical gel filtration 
H60A/H80A For EMSA and analytical gel filtration 
W50A/H52A/C53A/H57A For analytical gel filtration 
  
 
Table S-2: Crystallization kits  
 
Hampton Research Qiagen Crystalgen 
Crystal Screen I  JCSG+ Suite CryoMax 
Crystal Screen II  PACT Suite NaMax 
Grid Screen NaCl Classics Suite MPDMax 
Grid Screen AS Classics II Suite PhosMax 
Grid Screen PEG 6000 ComPAS Suite AsMax 
Crystal Screen Lite Anions Suite MemMax 
Index Cations Suite  
Screen Cryo PH Clear Suite  
Natrix PH Clear II Suite  
 Protein Complex Suite 
 Nucleix Suite  
 MbClass Suite  
 MbClass II Suite  
 
